BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-92. [PMID: 12297848 DOI: 10.1053/jhep.2002.36128] [Cited by in Crossref: 681] [Cited by in F6Publishing: 596] [Article Influence: 32.4] [Reference Citation Analysis]
Number Citing Articles
1 Indira Chandran V, Wernberg CW, Lauridsen MM, Skytthe MK, Bendixen SM, Larsen FT, Hansen CD, Grønkjær LL, Siersbæk MS, Caterino TD, Detlefsen S, Møller HJ, Grøntved L, Ravnskjaer K, Moestrup SK, Thiele MS, Krag A, Graversen JH. Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness. Hepatology 2023;77:558-72. [PMID: 35712786 DOI: 10.1002/hep.32620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chen S, Yin T, Li L, Diao M, Huang T. Development and validation of non-invasive models in predicting advanced fibrosis of choledochal cyst. Pediatr Surg Int 2023;39:87. [PMID: 36682006 DOI: 10.1007/s00383-023-05373-6] [Reference Citation Analysis]
3 Amadou C, Nabi O, Serfaty L, Lacombe K, Boursier J, Mathurin P, Ribet C, de Ledinghen V, Zins M, Charles MA. Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort. Hepatology 2022;76:1438-51. [PMID: 35474232 DOI: 10.1002/hep.32540] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Feng L, Liu R, An K, Tang S, Wu J, Yang Q. TET3 as non-invasive screening tool for the detection of fibrosis in patients with chronic liver disease.. [DOI: 10.21203/rs.3.rs-2153645/v1] [Reference Citation Analysis]
5 Yang G, Zhuang L, Sun T, Yeo YH, Tao L, Zhang W, Ma W, Wu L, Yang Z, Yang Y, Xue D, Zhang J, Feng R, Matthias P. E, Dooley S, Seki E, Liu P, Liu C, Solimando AG. Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-9. [DOI: 10.1155/2022/1048104] [Reference Citation Analysis]
6 Chun HS, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Kim SU. Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. Dig Dis Sci 2022;67:3412-25. [PMID: 34476661 DOI: 10.1007/s10620-021-07157-1] [Reference Citation Analysis]
7 Meneses D, Olveira A, Corripio R, Méndez MD, Romero M, Calvo-Viñuelas I, González-Pérez-de-Villar N, de-Cos-Blanco AI. The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods. Obes Surg 2022. [PMID: 35697996 DOI: 10.1007/s11695-022-06153-2] [Reference Citation Analysis]
8 Niu L, Thiele M, Geyer PE, Rasmussen DN, Webel HE, Santos A, Gupta R, Meier F, Strauss M, Kjaergaard M, Lindvig K, Jacobsen S, Rasmussen S, Hansen T, Krag A, Mann M. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat Med 2022. [PMID: 35654907 DOI: 10.1038/s41591-022-01850-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
9 Li T, Wang P, Gong X, Chong W, Hai Y, You C, Kang J, Fang F, Zhang Y. Prevalence and Prognostic Significance of Liver Fibrosis in Patients With Aneurysmal Subarachnoid Hemorrhage. Front Neurol 2022;13:850405. [DOI: 10.3389/fneur.2022.850405] [Reference Citation Analysis]
10 Nabi O, Boursier J, Lacombe K, Mathurin P, de Ledinghen V, Goldberg M, Zins M, Serfaty L. Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study). Dig Dis Sci 2022;67:2584-93. [PMID: 34031802 DOI: 10.1007/s10620-021-07032-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Thévenot T, Vendeville S, Weil D, Akkouche L, Calame P, Canivet CM, Vanlemmens C, Richou C, Cervoni JP, Seronde MF, Di Martino V, Boursier J. Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study. PLoS One 2022;17:e0266965. [PMID: 35617294 DOI: 10.1371/journal.pone.0266965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 He HM, He C, You ZB, Zhang SC, Lin XQ, Luo MQ, Lin MQ, Zhang LW, Lin KY, Guo YS. Non-Invasive Liver Fibrosis Scores Are Associated With Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention. Angiology 2022;:33197221105745. [PMID: 35642134 DOI: 10.1177/00033197221105745] [Reference Citation Analysis]
13 Garbuzenko DV. Principles of diagnosis and treatment of alcohol-induced liver fibrosis. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-7-104-114] [Reference Citation Analysis]
14 Melania G, Luisella V, Salvina DP, Francesca G, Amedea Silvia T, Fabrizia B, Maristella M, Filomena N, Kyriazoula C, Vassalle C. Concordance between indirect fibrosis and steatosis indices and their predictors in subjects with overweight/obesity. Eat Weight Disord 2022. [PMID: 35527326 DOI: 10.1007/s40519-022-01400-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pérez-Is L, Collazos J, de la Fuente B, Morano L, Rivas-Carmenado M, Rodriguez M, Romero-Favela A, Fonseca-González GJ, Melón S, Valle-Garay E, Asensi V. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy. Sci Rep 2022;12:3828. [PMID: 35264591 DOI: 10.1038/s41598-022-07548-y] [Reference Citation Analysis]
16 Moreno-Vedia J, Rosales R, Ozcariz E, Llop D, Lahuerta M, Benavent M, Rodríguez-Calvo R, Plana N, Pedragosa A, Masana L, Castro A, Ibarretxe D, Girona J. Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:775677. [PMID: 35082753 DOI: 10.3389/fendo.2021.775677] [Reference Citation Analysis]
17 Nabi O, Boursier J, Lapidus N, Mathurin P, de Ledinghen V, Petit JM, Goldberg M, Zins M, Lacombe K, Serfaty L. The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO). Liver Int 2022;42:595-606. [PMID: 35066992 DOI: 10.1111/liv.15171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Blanes-Vidal V, Lindvig KP, Thiele M, Nadimi ES, Krag A. Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care. Sci Rep 2022;12:2914. [PMID: 35190650 DOI: 10.1038/s41598-022-06998-8] [Reference Citation Analysis]
19 Segura-Azuara NLÁ, Varela-Chinchilla CD, Trinidad-Calderón PA. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Front Med (Lausanne) 2021;8:774079. [PMID: 35096868 DOI: 10.3389/fmed.2021.774079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 张 引. Research Progress of Serological Index in Diagnosis of Liver Fibrosis. MD 2022;12:89-94. [DOI: 10.12677/md.2022.122014] [Reference Citation Analysis]
21 Kaur N, Goyal G, Garg R, Tapasvi C, Chawla S, Kaur R. Potential role of noninvasive biomarkers during liver fibrosis. World J Hepatol 2021; 13(12): 1919-1935 [DOI: 10.4254/wjh.v13.i12.1919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kim HM, Lee YH. The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008-2011). Endocrinol Metab (Seoul) 2021. [PMID: 34809412 DOI: 10.3803/EnM.2021.1087] [Reference Citation Analysis]
23 Bhattacharya S, Kalra S, Kapoor N, Singla R, Dutta D, Aggarwal S, Khandelwal D, Surana V, Dhingra A, Kantroo V, Chittawar S, Deka N, Bindal V, Dutta P. Expert opinion on the preoperative medical optimization of adults with diabetes undergoing metabolic surgery. World J Diabetes 2021; 12(10): 1587-1621 [PMID: 34754367 DOI: 10.4239/wjd.v12.i10.1587] [Reference Citation Analysis]
24 Xu X, Wang W, Zhang Q, Cai W, Wu M, Qin T, Liu H. A Generic Nomogram Predicting the Stage of Liver Fibrosis Based on Serum Biochemical Indicators Among Chronic Hepatitis B Patients. Front Med (Lausanne) 2021;8:669800. [PMID: 34616750 DOI: 10.3389/fmed.2021.669800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Chemello L, Padalino M, Zanon C, Benvegnu' L, Biffanti R, Mancuso D, Cavalletto L. Role of Transient Elastography to Stage Fontan-Associated Liver Disease (FALD) in Adults with Single Ventricle Congenital Heart Disease Correction. J Cardiovasc Dev Dis 2021;8:117. [PMID: 34677186 DOI: 10.3390/jcdd8100117] [Reference Citation Analysis]
26 Fandler-Höfler S, Stauber RE, Kneihsl M, Wünsch G, Haidegger M, Poltrum B, Pichler A, Deutschmann H, Enzinger C, Fickert P, Gattringer T. Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke. Ther Adv Neurol Disord 2021;14:17562864211037239. [PMID: 34484426 DOI: 10.1177/17562864211037239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Przekop D, Klapaczynski J, Grytczuk A, Gruszewska E, Gietka A, Panasiuk A, Golaszewski S, Cylwik B, Chrostek L. Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C. J Clin Med 2021;10:3951. [PMID: 34501398 DOI: 10.3390/jcm10173951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Delle Monache M, Petrelli A, Rossi A, Cecere R, Mirisola C, Costanzo G, Francia C, Cerini F, Cavani A, Nosotti L. Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy. Can J Infect Dis Med Microbiol 2021;2021:3068690. [PMID: 34426755 DOI: 10.1155/2021/3068690] [Reference Citation Analysis]
29 De Bruyne R, Vandekerckhove K, Van Overschelde H, Hendricx F, Vande Walle C, De Groote K, Panzer J, De Wolf D, Van Biervliet S, Bové T, François K. Non-invasive assessment of liver abnormalities in pediatric Fontan patients. Eur J Pediatr 2021. [PMID: 34231051 DOI: 10.1007/s00431-021-04163-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zientarska A, Kaczmarek M, Mozer-Lisewska I, Kowala-Piaskowska A, Witkowska A, Żeromski J. Treg cells in the course of chronic hepatitis C virus infection partially normalize in longitudinal observation after successful DAA treatment regardless of hepatic fibrosis stage. Clin Exp Hepatol 2021;7:196-204. [PMID: 34295988 DOI: 10.5114/ceh.2021.107122] [Reference Citation Analysis]
31 Fuster D, García-Calvo X, Zuluaga P, Bolao F, Muga R. Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use. World J Gastroenterol 2021; 27(23): 3223-3237 [PMID: 34163107 DOI: 10.3748/wjg.v27.i23.3223] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Romero-Cristóbal M, Clemente-Sánchez A, Piñeiro P, Cedeño J, Rayón L, Del Río J, Ramos C, Hernández DA, Cova M, Caballero A, Garutti I, García-Olivares P, Hortal J, Guerrero JE, García R, Bañares R, Rincón D. Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients. Therap Adv Gastroenterol 2021;14:17562848211023410. [PMID: 34178116 DOI: 10.1177/17562848211023410] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Cao YX, Zhang M, Zhang HW, Jin JL, Liu HH, Zhang Y, Guo YL, Wu NQ, Zhu CG, Xu RX, Gao Y, Dong Q, Sun J, Li JJ. Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study. Liver Int 2021;41:1294-304. [PMID: 33389804 DOI: 10.1111/liv.14780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
34 Guerra-ruiz AR, Casals G, Iruzubieta P, Lalana M, Leis A, López RM, Crespo J, Morales-ruiz M. Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:209-219. [DOI: 10.1515/almed-2020-0062] [Reference Citation Analysis]
35 Guerra-ruiz AR, Casals G, Iruzubieta P, Lalana M, Leis A, López RM, Crespo J, Morales-ruiz M. Biochemical assessment of metabolic associated fatty liver disease. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2021;2:199-208. [DOI: 10.1515/almed-2021-0009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Bukhari T, Jafri L, Majid H, Ahmed S, Khan AHH, Abid S, Raza A, Siddiqui I. Diagnostic Accuracy of the Forns Score for Liver Cirrhosis in Patients With Chronic Viral Hepatitis. Cureus 2021;13:e14477. [PMID: 33996335 DOI: 10.7759/cureus.14477] [Reference Citation Analysis]
37 Ohuchi H, Hayama Y, Nakajima K, Kurosaki K, Shiraishi I, Nakai M. Incidence, Predictors, and Mortality in Patients With Liver Cancer After Fontan Operation. J Am Heart Assoc 2021;10:e016617. [PMID: 33538186 DOI: 10.1161/JAHA.120.016617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
38 Liu HH, Cao YX, Jin JL, Hua Q, Li YF, Guo YL, Zhu CG, Wu NQ, Gao RL, Li JJ. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention. J Am Heart Assoc 2021;10:e018869. [PMID: 33506689 DOI: 10.1161/JAHA.120.018869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
39 Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, Marrazzo A, Romagnoli D, Targher G, Lonardo A. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel) 2021;11:98. [PMID: 33435415 DOI: 10.3390/diagnostics11010098] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
40 Toyoda H, Tada T, Yasuda S, Mizuno K, Ito T, Kumada T. Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response. Clin Infect Dis 2020;70:1208-14. [PMID: 31056696 DOI: 10.1093/cid/ciz359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
41 Mao X, Liu Z, Shi O, Yu K, Jiang Y, Jin L, Zhang T, Chen X. Non-invasive fibrosis markers are associated with mortality risk in both general populations and non-alcoholic fatty liver disease patients. Hepatol Res 2021;51:90-101. [PMID: 32946623 DOI: 10.1111/hepr.13570] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Semmler G, Bachmayer S, Wernly S, Wernly B, Niederseer D, Huber-Schönauer U, Stickel F, Aigner E, Datz C. Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease. PLoS One 2020;15:e0244514. [PMID: 33382757 DOI: 10.1371/journal.pone.0244514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Kogiso T, Tokushige K. Fontan-associated liver disease and hepatocellular carcinoma in adults. Sci Rep 2020;10:21742. [PMID: 33303924 DOI: 10.1038/s41598-020-78840-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
44 Hara T, Ohara T, Taniguchi M, Sakai T, Oka K, Iwai N, Tsuji T, Okuda T, Komaki T, Sakagami J, Kagawa K. Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy. Case Reports Hepatol 2020;2020:8824974. [PMID: 33123390 DOI: 10.1155/2020/8824974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Han MAT. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome. Life (Basel) 2020;10:E198. [PMID: 32933184 DOI: 10.3390/life10090198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kogiso T, Sagawa T, Kodama K, Taniai M, Hashimoto E, Tokushige K. Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population. J Gastroenterol Hepatol 2020;35:1579-89. [PMID: 31975453 DOI: 10.1111/jgh.14989] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
47 Kang NL, Zhang JM, Lin MX, Chen XD, Huang ZX, Zhu YY, Liu YR, Zeng DW. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World J Gastroenterol 2020; 26(27): 3952-3962 [PMID: 32774069 DOI: 10.3748/wjg.v26.i27.3952] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Kang N, Zhang J, Lin M, Chen X, Huang Z, Zhu Y, Liu Y, Zeng D. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. WJG 2020;26:3948-58. [DOI: 10.3748/wjg.v26.i27.3948] [Reference Citation Analysis]
49 Fragkos KC, Picasso Bouroncle MC, Kumar S, Caselton L, Menys A, Bainbridge A, Taylor SA, Torrealdea F, Kumagai T, Di Caro S, Rahman F, Macnaughtan J, Chouhan MD, Mehta S. Serum Scoring and Quantitative Magnetic Resonance Imaging in Intestinal Failure-Associated Liver Disease: A Feasibility Study. Nutrients 2020;12:E2151. [PMID: 32707726 DOI: 10.3390/nu12072151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
50 Androutsakos T, Schina M, Pouliakis A, Kontos A, Sipsas N, Hatzis G. Liver Fibrosis Assessment in a Cohort of Greek HIV Mono-Infected Patients by Non-Invasive Biomarkers. Curr HIV Res 2019;17:173-82. [PMID: 31549590 DOI: 10.2174/1570162X17666190809153245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Knop V, Mauss S, Goeser T, Geier A, Zimmermann T, Herzer K, Postel N, Friedrich-Rust M, Hofmann WP; German Hepatitis C-Registry. Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry. J Viral Hepat 2020;27:690-8. [PMID: 32096310 DOI: 10.1111/jvh.13280] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
52 Marasco G, Colecchia A, Silva G, Rossini B, Eusebi LH, Ravaioli F, Dajti E, Alemanni LV, Colecchia L, Renzulli M, Golfieri R, Festi D. Non-invasive tests for the prediction of primary hepatocellular carcinoma. World J Gastroenterol 2020; 26(24): 3326-3343 [PMID: 32655261 DOI: 10.3748/wjg.v26.i24.3326] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
53 Joseph J. Serum Marker Panels for Predicting Liver Fibrosis - An Update. Clin Biochem Rev 2020;41:67-73. [PMID: 32518428 DOI: 10.33176/AACB-20-00002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Asphaug L, Thiele M, Krag A, Melberg HO. Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis. Hepatology 2020;71:2093-104. [PMID: 31595545 DOI: 10.1002/hep.30979] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
55 Song DS, Chang UI, Kang SG, Song SW, Yang JM. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease. Gut Liver 2019;13:658-68. [PMID: 30970434 DOI: 10.5009/gnl18439] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
56 Altamirano J, Qi Q, Choudhry S, Abdallah M, Singal AK, Humar A, Bataller R, Borhani AA, Duarte-Rojo A. Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease. Transl Gastroenterol Hepatol. 2020;5:31. [PMID: 32258535 DOI: 10.21037/tgh.2019.11.14] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
57 Zirnis AE, Straume Z, Bērziņa R, Māliņa-bambīte J, Derovs A, Zeltiņa I. Establishing Cut-Offs for Non-Invasive Liver Tests to Detect Cirrhosis at a High Sensitivity. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020;74:118-124. [DOI: 10.2478/prolas-2020-0019] [Reference Citation Analysis]
58 Goñi Esarte S, Juanbeltz R, Zozaya JM, Úriz JI, Castilla J, Herrero JI. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents. Gastroenterol Hepatol 2020;43:248-55. [PMID: 32192765 DOI: 10.1016/j.gastrohep.2019.03.017] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and treatment of hepatic fibrosis (2019). J Dig Dis 2020;21:127-38. [PMID: 32108989 DOI: 10.1111/1751-2980.12854] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
60 Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 2020;33. [PMID: 32102898 DOI: 10.1128/cmr.00046-19] [Cited by in Crossref: 100] [Cited by in F6Publishing: 106] [Article Influence: 33.3] [Reference Citation Analysis]
61 Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2:100067. [PMID: 32118201 DOI: 10.1016/j.jhepr.2020.100067] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 22.7] [Reference Citation Analysis]
62 Shiha G, Mousa N. Noninvasive Biomarkers for Liver Fibrosis. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_36] [Reference Citation Analysis]
63 Hagström H, Talbäck M, Andreasson A, Walldius G, Hammar N. Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease. Gastroenterology 2020;158:200-14. [PMID: 31563624 DOI: 10.1053/j.gastro.2019.09.008] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 25.7] [Reference Citation Analysis]
64 Younossi ZM, Henry L. Are Noninvasive Scoring Systems for Persons With Chronic Liver Disease Ready for Prime Time? Gastroenterology 2020;158:40-2. [PMID: 31743732 DOI: 10.1053/j.gastro.2019.11.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
65 Cho Y, Choi YI, Oh S, Han J, Joo SK, Lee DH, Jung YJ, Kim BG, Lee KL, Kim W. Point shear wave elastography predicts fibrosis severity and steatohepatitis in alcohol-related liver disease. Hepatol Int 2020;14:270-80. [PMID: 31858403 DOI: 10.1007/s12072-019-10009-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
66 Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Hu PJ, Bair MJ. Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C. J Microbiol Immunol Infect 2020;53:542-9. [PMID: 31831303 DOI: 10.1016/j.jmii.2019.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
67 Ahmed Y, Hussein RS, Basha TA, Khalifa AM, Ibrahim AS, Abdelmoaty AS, Abdella HM, Fahmy AS. Detecting liver fibrosis using a machine learning-based approach to the quantification of the heart-induced deformation in tagged MR images. NMR Biomed. 2020;33:e4215. [PMID: 31730265 DOI: 10.1002/nbm.4215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
68 Wu J, Guo N, Zhang X, Xiong C, Liu J, Xu Y, Fan J, Yu J, Zhao X, Liu B, Wang W, Zhang J, Cao H, Li L. HEV-LF(S) : A novel scoring model for patients with hepatitis E virus-related liver failure. J Viral Hepat 2019;26:1334-43. [PMID: 31294523 DOI: 10.1111/jvh.13174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
69 Khatun M, Ray RB. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells 2019;8:E1249. [PMID: 31615075 DOI: 10.3390/cells8101249] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 18.5] [Reference Citation Analysis]
70 Izumi G, Takeda A, Yamazawa H, Sasaki O, Kato N, Asai H, Tachibana T, Matsui Y. Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion. Heart Vessels 2020;35:586-92. [PMID: 31562553 DOI: 10.1007/s00380-019-01515-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Smirne C, Rigamonti C, De Benedittis C, Sainaghi PP, Bellan M, Burlone ME, Castello LM, Avanzi GC. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. Dis Markers 2019;2019:2304931. [PMID: 31583026 DOI: 10.1155/2019/2304931] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
72 Moscoso CG, Steer CJ. "Let my liver rather heat with wine" - a review of hepatic fibrosis pathophysiology and emerging therapeutics. Hepat Med 2019;11:109-29. [PMID: 31565001 DOI: 10.2147/HMER.S213397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
73 Huang Y, Chen Y, Zhu H, Li W, Ge Y, Huang X, He J. A liver fibrosis staging method using cross-contrast network. Expert Systems with Applications 2019;130:124-31. [DOI: 10.1016/j.eswa.2019.03.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
74 Sahin T, Serin A, Emek E, Bozkurt B, Arikan BT, Tokat Y. Effectiveness of Noninvasive Fibrosis Markers for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis. Transplantation Proceedings 2019;51:2397-402. [DOI: 10.1016/j.transproceed.2019.01.193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
75 Tada T, Toyoda H, Yasuda S, Miyake N, Kumada T, Kurisu A, Ohisa M, Akita T, Tanaka J. Natural history of liver-related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model. J Med Virol 2019;91:1837-44. [PMID: 31254403 DOI: 10.1002/jmv.25533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
76 Hu J, Zhang X, Gu J, Yang M, Zhang X, Zhao H, Li L. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B. Eur J Gastroenterol Hepatol 2019;31:817-23. [PMID: 30543572 DOI: 10.1097/MEG.0000000000001336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
77 Lens S, Torres F, Bonacci M, Bartres C, Pocurull A, Mariño Z, Londoño MC, Rodríguez-Tajes S, Forns X. Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy. Dig Liver Dis 2019;51:875-81. [PMID: 30558865 DOI: 10.1016/j.dld.2018.11.019] [Reference Citation Analysis]
78 Badano MN, Parodi C, Aloisi N, Corti M, Elizalde de Bracco MM, Baré P. Influence of Hepatitis C virus coinfection on immune reconstitution in HIV subjects. Med Microbiol Immunol 2019;208:747-56. [PMID: 31147782 DOI: 10.1007/s00430-019-00619-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Komatsu H, Inui A, Kishiki K, Kawai H, Yoshio S, Osawa Y, Kanto T, Fujisawa T. Liver disease secondary to congenital heart disease in children. Expert Review of Gastroenterology & Hepatology 2019;13:651-66. [DOI: 10.1080/17474124.2019.1621746] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
80 Attallah AM, Albannan MS, Omran MM, Zayed R, Saif S, Farid A, Hassany M, Yosry A, Omran D. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. Br J Biomed Sci 2019;76:105-10. [PMID: 30924403 DOI: 10.1080/09674845.2019.1600325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Preveden T, Vereš B, Ružić M, Pete M, Luzza F, Pellicano R, Abenavoli L. Noninvasive assessment of liver fibrosis in chronic hepatitis C virus patients compared to liver biopsy: the experience of tertiary level hospital in Serbia. Minerva Med 2020;111:197-202. [PMID: 31081313 DOI: 10.23736/S0026-4806.19.06109-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
82 Chrostek L, Przekop D, Gruszewska E, Gudowska-Sawczuk M, Cylwik B. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics. Biomed Res Int 2019;2019:3646975. [PMID: 31192254 DOI: 10.1155/2019/3646975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
83 Choi JW, Lee CH, Park JS. Comparison of laboratory indices of non-alcoholic fatty liver disease for the detection of incipient kidney dysfunction. PeerJ 2019;7:e6524. [PMID: 30867987 DOI: 10.7717/peerj.6524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Daniels SJ, Leeming DJ, Eslam M, Hashem AM, Nielsen MJ, Krag A, Karsdal MA, Grove JI, Neil Guha I, Kawaguchi T, Torimura T, McLeod D, Akiba J, Kaye P, de Boer B, Aithal GP, Adams LA, George J. ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis. Hepatology 2019;69:1075-86. [PMID: 30014517 DOI: 10.1002/hep.30163] [Cited by in Crossref: 117] [Cited by in F6Publishing: 105] [Article Influence: 29.3] [Reference Citation Analysis]
85 Castera L. Noninvasive Tests of Liver Fibrosis. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch30] [Reference Citation Analysis]
86 Agbim U, Asrani SK. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Review of Gastroenterology & Hepatology 2019;13:361-74. [DOI: 10.1080/17474124.2019.1579641] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
87 Köksal İ, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydoğdu Ö, Turgut H, Gürbüz Y, Dağlı Ö, Gökal AA, Güner R, Kuruüzüm Z, Tarakçı H, Beslen N, Erdoğan S, Özdener F, Study Group TCHC. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study. Turk J Gastroenterol 2018;29:464-72. [PMID: 30249562 DOI: 10.5152/tjg.2018.16597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
88 Knop V, Hofmann WP, Buggisch P, Klinker H, Mauss S, Günther R, Hinrichsen H, Hüppe D, Pfeiffer-Vornkahl H, Simon KG, Berg T, Manns MP, Friedrich-Rust M; German Hepatitis C-Registry. Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment. J Viral Hepat 2019;26:224-30. [PMID: 30315694 DOI: 10.1111/jvh.13021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
89 Zhang Y, Zheng Y, Yang X, Liu X, Zhang H, Xu X, Meng F. Comparison of Acoustic Structure Quantification, Transient Elastography (FibroScan) and Histology in Patients with Chronic Hepatitis B and without Moderate to Severe Hepatic Steatosis. Ultrasound Med Biol 2019;45:684-92. [PMID: 30638967 DOI: 10.1016/j.ultrasmedbio.2018.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Yuyun D, Zhihua T, Haijun W, Zhaoping L, Xiaoli Z, Wenfang X, Faxiang J, Hongmei L. Predictive value of the red blood cell distribution width-to-platelet ratio for hepatic fibrosis. Scand J Gastroenterol 2019;54:81-6. [PMID: 30663454 DOI: 10.1080/00365521.2018.1558786] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
91 Camarata MA, Weiss KH, Schilsky ML. Special Treatment Considerations for Wilson Disease. Wilson Disease 2019. [DOI: 10.1016/b978-0-12-811077-5.00023-2] [Reference Citation Analysis]
92 Gressner AM, Gressner OA. Forns-Index. Springer Reference Medizin 2019. [DOI: 10.1007/978-3-662-48986-4_1162] [Reference Citation Analysis]
93 El Din Mohamed Abdo A, Mahmoud Mohy El Din K, El Din Saeed Bedewy E, Abdel Haleem Abo Elwafa R, Adel Abdel Aziz M. Plasma soluble CD 163 level as a marker of oesophageal varices in cirrhotic patients. Alexandria Journal of Medicine 2018;54:567-580. [DOI: 10.1016/j.ajme.2017.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
94 Inoyatova FI, Inogamova GZ. Liver Cirrhosis of the Viral Etiology in Children. Det infekc 2018;17:29-33. [DOI: 10.22627/2072-8107-2018-17-4-29-33] [Reference Citation Analysis]
95 Wu D, Rao Q, Chen W, Ji F, Xie Z, Huang K, Chen E, Zhao Y, Ouyang X, Zhang S, Jiang Z, Zhang L, Xu L, Gao H, Li L. Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B. Liver Int 2018;38:1930-9. [PMID: 29654711 DOI: 10.1111/liv.13756] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
96 Rudolph B, Bjorklund N, Ovchinsky N, Kogan-Liberman D, Perez A, Liszewski M, Levin TL, Ewart M, Liu Q, Xue X, Viswanathan S, Strickler HD. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design. Contemp Clin Trials 2018;75:51-8. [PMID: 30401631 DOI: 10.1016/j.cct.2018.10.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Wang L, Fan YX, Dou XG. Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B. World J Clin Cases 2018; 6(12): 521-530 [PMID: 30397608 DOI: 10.12998/wjcc.v6.i12.521] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
98 Chen Y, Li Y, Li N, Fan X, Li C, Zhang P, Han Q, Liu Z. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Dis Markers 2018;2018:3924732. [PMID: 30405859 DOI: 10.1155/2018/3924732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Lubner MG, Jones D, Kloke J, Said A, Pickhardt PJ. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus. Br J Radiol 2019;92:20180153. [PMID: 30182750 DOI: 10.1259/bjr.20180153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
100 Drazilova S, Janicko M, Skladany L, Kristian P, Oltman M, Szantova M, Krkoska D, Mazuchova E, Piesecka L, Vahalova V, Rac M, Schreter I, Virag L, Koller T, Liptakova A, Ondrasova M, Jarcuska P. Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Can J Gastroenterol Hepatol 2018;2018:6095097. [PMID: 30402450 DOI: 10.1155/2018/6095097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
101 Salama M, Nomir M, Fahmi M, El-gayar A, El-shishtawy M. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Sci Pharm 2018;86:44. [DOI: 10.3390/scipharm86040044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
102 Zhang J, Du X, Zhou Z, Lv F, Yu Y. Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study. J Int Med Res 2019;47:122-32. [PMID: 30213226 DOI: 10.1177/0300060518796760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
103 Lubner MG, Pickhardt PJ. Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis. Gastroenterol Clin North Am 2018;47:569-84. [PMID: 30115438 DOI: 10.1016/j.gtc.2018.04.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
104 Navrotsky AN. [Diagnostic possibilities of methods for the evaluation of liver fibrosis in chronic viral hepatitis]. Ter Arkh 2016;88:149-55. [PMID: 28635835 DOI: 10.17116/terarkh20168811149-155] [Reference Citation Analysis]
105 Ouyang GX, Zhang YM, Zhu SL, Wang P, Ren Y, Li JH, Liu YK, Chen J, Xiang BD, Li LQ, Liu JY, Zhang ZM. A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep 2018;8:13074. [PMID: 30166568 DOI: 10.1038/s41598-018-31351-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
106 Ukawa S, Tamakoshi A, Murakami Y, Kiyohara Y, Yamada M, Nagai M, Satoh A, Miura K, Ueshima H, Okamura T, EPOCH-JAPAN Research Group. Pooled Analysis of the Associations between Body Mass Index, Total Cholesterol, and Liver Cancer-related Mortality in Japan. Asian Pac J Cancer Prev 2018;19:2089-95. [PMID: 30139206 DOI: 10.22034/APJCP.2018.19.8.2089] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
107 Han E, Lee YH, Kim BK, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Han KH, Kim SU. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B. Aliment Pharmacol Ther 2018;48:300-12. [PMID: 29920701 DOI: 10.1111/apt.14843] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
108 Ackerman T, Geerts A, Van Vlierberghe H, De Backer J, François K. Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening. Pediatr Cardiol 2018;39:1604-13. [PMID: 30032312 DOI: 10.1007/s00246-018-1937-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
109 Ke MY, Zhang M, Su Q, Wei S, Zhang J, Wang Y, Wu R, Lv Y. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection. J Surg Res 2018;231:403-10. [PMID: 30278960 DOI: 10.1016/j.jss.2018.05.049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
110 Navarta LM, Espul CA, Acosta-Rivero N. High prevalence of a variety of autoantibodies in a population of hepatitis C virus-infected individuals. APMIS 2018;126:515-22. [PMID: 29924449 DOI: 10.1111/apm.12850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
111 Shen FF, Wang Y, Wang YF, Zheng RD, Xian JC, Shi JP, Qu Y, Dong YW, Xu MY, Lu LG. Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model. J Transl Med 2018;16:166. [PMID: 29914513 DOI: 10.1186/s12967-018-1538-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
112 Majumdar A, Pinzani M. Non-invasive Assessment of Fibrosis and Cirrhosis. Sherlock's Diseases of the Liver and Biliary System 2018. [DOI: 10.1002/9781119237662.ch7] [Reference Citation Analysis]
113 Zeremski M, Martinez A. Liver Disease and Fibrosis Assessment in Substance Use-Related Disorders. Clin Pharmacol Drug Dev 2017;6:164-8. [PMID: 28263455 DOI: 10.1002/cpdd.312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Yue Z, Hong D, Peili F, Yuli Z, Yuan Z, Wenjiao Z, Wenping W. Non-Invasive Assessment of Liver Fibrosis in a Rat Model: Comparison of Shear Wave Elastography with Serologic Tests. Iran J Radiol 2018;15. [DOI: 10.5812/iranjradiol.60665] [Reference Citation Analysis]
115 Sanvisens A, Muñoz A, Bolao F, Zuluaga P, Farré M, Jarrin I, Tor J, Muga R. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder? Drug Alcohol Depend 2018;188:180-6. [PMID: 29778771 DOI: 10.1016/j.drugalcdep.2018.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
116 Wong GL. Non-invasive assessments for liver fibrosis: The crystal ball we long for. J Gastroenterol Hepatol 2018;33:1009-15. [PMID: 29380413 DOI: 10.1111/jgh.14103] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
117 Kakisaka K, Suzuki Y, Fujiwara Y, Abe T, Yonezawa M, Kuroda H, Ishida K, Sugai T, Takikawa Y. Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease. J Gastroenterol 2018;53:1285-91. [PMID: 29680867 DOI: 10.1007/s00535-018-1468-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
118 Mendes LC, Stucchi RS, Vigani AG. Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies. Hepat Med. 2018;10:13-22. [PMID: 29662329 DOI: 10.2147/hmer.s125234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
119 Caballería L, Torán P, Caballería J. Markers of hepatic fibrosis. Medicina Clínica (English Edition) 2018;150:310-316. [DOI: 10.1016/j.medcle.2018.02.005] [Reference Citation Analysis]
120 Tada T, Kumada T, Toyoda H, Kobayashi N, Akita T, Tanaka J. Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers. J Gastroenterol Hepatol 2018;33:918-25. [PMID: 28914957 DOI: 10.1111/jgh.13989] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
121 Thiele M, Madsen BS, Hansen JF, Detlefsen S, Antonsen S, Krag A. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease. Gastroenterology 2018;154:1369-79. [PMID: 29317276 DOI: 10.1053/j.gastro.2018.01.005] [Cited by in Crossref: 114] [Cited by in F6Publishing: 118] [Article Influence: 22.8] [Reference Citation Analysis]
122 Lee EC, Park SJ, Han SS, Shim JR, Park HM, Lee SD, Kim SH. Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma. J Gastroenterol Hepatol 2018;33:958-65. [PMID: 28843035 DOI: 10.1111/jgh.13966] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
123 Caballería L, Torán P, Caballería J. Marcadores de fibrosis hepática. Medicina Clínica 2018;150:310-6. [DOI: 10.1016/j.medcli.2017.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
124 Yan L, Deng Y, Zhou J, Zhao H, Wang G; China HepB-Related Fibrosis Assessment Research Group. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection 2018;46:385-93. [PMID: 29600444 DOI: 10.1007/s15010-018-1136-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
125 Wang XC, Zhang XY, Zhang X, Yuan ZX, Li XH, Wang JC, Sun B, Lu XJ. Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FM(VCTE) algorithm. J Hepatol 2018;68:602-3. [PMID: 28993184 DOI: 10.1016/j.jhep.2017.08.038] [Reference Citation Analysis]
126 Gao H, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Qin R, Yan L, Xiao G. Preoperatively staging liver fibrosis using noninvasive method in hepatitis B virus-infected hepatocellular carcinoma patients. Oncotarget 2017;8:4289-300. [PMID: 28008144 DOI: 10.18632/oncotarget.14024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Liao R, Fu YP, Wang T, Deng ZG, Li DW, Fan J, Zhou J, Feng GS, Qiu SJ, Du CY. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China. Oncotarget 2017;8:1774-87. [PMID: 27662665 DOI: 10.18632/oncotarget.12152] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
128 Kelly ML, Riordan SM, Bopage R, Lloyd AR, Post JJ. Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study. PLoS One 2018;13:e0192763. [PMID: 29438397 DOI: 10.1371/journal.pone.0192763] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
129 Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. J Hepatol 2018;68:305-15. [PMID: 29154965 DOI: 10.1016/j.jhep.2017.11.013] [Cited by in Crossref: 315] [Cited by in F6Publishing: 310] [Article Influence: 63.0] [Reference Citation Analysis]
130 Vinciguerra T, Brunati A, David E, Longo F, Pinon M, Ricceri F, Castellino L, Piga A, Giraudo MT, Tandoi F. Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children. Pediatr Transplant. 2018;22. [PMID: 29369488 DOI: 10.1111/petr.13125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
131 Lambrecht J, Verhulst S, Mannaerts I, Reynaert H, van Grunsven LA. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard? Biochim Biophys Acta Mol Basis Dis. 2018;1864:1024-1036. [PMID: 29329986 DOI: 10.1016/j.bbadis.2018.01.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
132 Li N, Jiang Y, Gong G, Han G, Ma J. Non-Invasive Assessment Model of Liver Disease Severity by Serum Markers Using Cloud Computing and Internet of Things. IEEE Access 2018;6:33969-33976. [DOI: 10.1109/access.2018.2849016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
133 Liu CH, Liu CJ, Hong CM, Su TH, Yang HC, Chen KM, Huang YP, Yeh YM, Tien HL, Liu YC, Kao JH, Chen DS, Chen PJ. A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients. J Gastroenterol Hepatol 2018;33:291-7. [PMID: 28548299 DOI: 10.1111/jgh.13834] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
134 Pembroke T, Sebastiani G. Non-invasive Serum Markers of Fibrosis. Diagnostic Methods for Cirrhosis and Portal Hypertension 2018. [DOI: 10.1007/978-3-319-72628-1_5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
135 Chan HL, Wong VW. Non-invasive Assessment of Liver Disease. Hepatitis B Virus and Liver Disease 2018. [DOI: 10.1007/978-981-10-4843-2_9] [Reference Citation Analysis]
136 Matta B, Lee TH, Patel K. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. Curr HIV/AIDS Rep 2016;13:279-88. [PMID: 27485838 DOI: 10.1007/s11904-016-0329-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
137 Zhang Z, Li J, Wang P, He T, Ouyang Y, Huang Y. Nomogram for cirrhosis in patients with chronic hepatitis B: A simple self-assessed scale for individual risk of cirrhosis. Sci Rep 2017;7:17493. [PMID: 29235488 DOI: 10.1038/s41598-017-17685-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
138 Ahmed Hassan E, Sharaf El-Din Abd El-Rehim A, Ahmed Sayed ZE, Farah Mohamed Kholef E, Sabry A, Abd El-Rehim Abo Elhagag N. VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C. Hepatol Res 2017;47:1408-16. [PMID: 28247581 DOI: 10.1111/hepr.12884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
139 Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA 2018;4:FSO250. [PMID: 29255622 DOI: 10.4155/fsoa-2017-0083] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 11.3] [Reference Citation Analysis]
140 Deng Y, Zhao H, Zhou J, Yan L, Wang G; China HepB-Related Fibrosis Assessment Research Group. Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT. BMC Infect Dis 2017;17:650. [PMID: 28962551 DOI: 10.1186/s12879-017-2728-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
141 Attallah AM, Omran D, Omran MM, Albannan MS, Zayed RA, Saif S, Farid A, Hassany M, Yosry A. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Br J Biomed Sci 2018;75:19-23. [PMID: 28945150 DOI: 10.1080/09674845.2017.1362950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
142 Wang L, Feng Y, Ma X, Wang G, Wu H, Xie X, Zhang C, Zhu Q. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis. PLoS One 2017;12:e0182969. [PMID: 28820885 DOI: 10.1371/journal.pone.0182969] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
143 Valkov I, Ivanova R, Alexiev A, Antonov K, Mateva L. Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C. J Clin Diagn Res 2017;11:OC15-20. [PMID: 28969178 DOI: 10.7860/JCDR/2017/28609.10459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
144 Kang J, Lee M. Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
145 Unalp-Arida A, Ruhl CE. Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology 2017;66:84-95. [PMID: 28195363 DOI: 10.1002/hep.29113] [Cited by in Crossref: 111] [Cited by in F6Publishing: 84] [Article Influence: 18.5] [Reference Citation Analysis]
146 Xie C, Ma B, Wang N, Wan L. Comparison of serological assessments in the diagnosis of liver fibrosis in bile duct ligation mice. Exp Biol Med (Maywood) 2017;242:1398-404. [PMID: 28669222 DOI: 10.1177/1535370217718179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
147 Shahabi M, Hassanpour H, Mashayekhi H. Rule extraction for fatty liver detection using neural networks. Neural Comput & Applic 2019;31:979-89. [DOI: 10.1007/s00521-017-3130-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
148 Chu PS, Nakamoto N, Taniki N, Ojiro K, Amiya T, Makita Y, Murata H, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ugamura A, Ikura A, Takeda K, Ebinuma H, Saito H, Kanai T. On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C. PLoS One. 2017;12:e0179096. [PMID: 28617830 DOI: 10.1371/journal.pone.0179096] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
149 Wei X, Wei H, Lin W, Hu Z, Zhang J. Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy. Medicine (Baltimore) 2017;96:e6807. [PMID: 28514295 DOI: 10.1097/MD.0000000000006807] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
150 Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. World J Virol 2017; 6(2): 36-45 [PMID: 28573088 DOI: 10.5501/wjv.v6.i2.36] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
151 Moqueet N, Kanagaratham C, Gill MJ, Hull M, Walmsley S, Radzioch D, Saeed S, Platt RW, Klein MB; Canadian Co-infection Cohort Study (CTN 222). A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection. PLoS One 2017;12:e0176282. [PMID: 28467457 DOI: 10.1371/journal.pone.0176282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
152 Pan AN, Xu WW, Luo YL, Yu HH, Hu YB, Sun QF, Ding JG, Wu YH. A novel system for predicting liver histopathology in patients with chronic hepatitis B. Medicine (Baltimore) 2017;96:e6465. [PMID: 28383410 DOI: 10.1097/MD.0000000000006465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
153 Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A. Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C. Sci Rep. 2017;7:46705. [PMID: 28425454 DOI: 10.1038/srep46705] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
154 Barreto AV, Alecrim VM, Medeiros TB, Domingues AL, Lopes EP, Martins JR, Nader HB, Diniz GT, Montenegro SM, Morais CN. New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni. Arq Gastroenterol 2017;54:51-6. [PMID: 28079240 DOI: 10.1590/S0004-2803.2017v54n1-10] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
155 Stasi C, Salomoni E, Arena U, Corti G, Montalto P, Bartalesi F, Marra F, Laffi G, Milani S, Zignego AL. Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study. Eur J Pharmacol. 2017;806:105-109. [PMID: 28414057 DOI: 10.1016/j.ejphar.2017.03.063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
156 Chen X, Wen H, Zhang X, Dong C, Lin H, Guo Y, Shan L, Yao S, Yang M, Le X, Liu Y. Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics. Clin Transl Gastroenterol. 2017;8:e84. [PMID: 28383564 DOI: 10.1038/ctg.2017.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
157 Gharib AM, Han MAT, Meissner EG, Kleiner DE, Zhao X, McLaughlin M, Matthews L, Rizvi B, Abd-Elmoniem KZ, Sinkus R, Levy E, Koh C, Myers RP, Subramanian GM, Kottilil S, Heller T, Kovacs JA, Morse CG. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. Biomed Res Int 2017;2017:2067479. [PMID: 28480218 DOI: 10.1155/2017/2067479] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
158 Khan MQ, Anand V, Hessefort N, Hassan A, Ahsan A, Sonnenberg A, Fimmel CJ. Utility of Electronic Medical record-based Fibrosis Scores in Predicting Advanced Cirrhosis in Patients with Hepatitic C Virus Infection. J Transl Int Med. 2017;5:43-48. [PMID: 28680838 DOI: 10.1515/jtim-2017-0011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
159 Chindamo MC, Boursier J, Luiz RR, Fouchard-Hubert I, Pannain VLN, de Araújo Neto JM, Coelho HSM, de Mello Perez R, Calès P, Villela-Nogueira CA. Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C. World J Hepatol 2017; 9(6): 310-317 [PMID: 28293380 DOI: 10.4254/wjh.v9.i6.310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
160 Nishikawa H, Hasegawa K, Ishii A, Takata R, Enomoto H, Yoh K, Kishino K, Shimono Y, Iwata Y, Nakano C, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation. Medicine (Baltimore) 2016;95:e4679. [PMID: 27583895 DOI: 10.1097/MD.0000000000004679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
161 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Hasegawa K, Nakano C, Takata R, Kishino K, Shimono Y, Sakai Y, Nishimura T, Aizawa N, Ikeda N, Takashima T, Ishii A, Iijima H, Nishiguchi S. Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. Medicine (Baltimore) 2016;95:e3920. [PMID: 27311000 DOI: 10.1097/MD.0000000000003920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
162 Parikh P, Ryan JD, Tsochatzis EA. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med. 2017;5:40. [PMID: 28251119 DOI: 10.21037/atm.2017.01.28] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 7.7] [Reference Citation Analysis]
163 Toson EA, Shiha GE, El-Mezayen HA, Samir W, El-Khininy MM. Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link. Eur J Gastroenterol Hepatol 2017;29:199-207. [PMID: 27930387 DOI: 10.1097/MEG.0000000000000775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
164 Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Tanaka J. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic. J Gastroenterol Hepatol 2017;32:451-8. [PMID: 27288655 DOI: 10.1111/jgh.13473] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
165 Eguiluz M, Andrés-otero M, De-blas I, Puente-lanzarote J, Lorente-pérez S. The Potential of Liver Fibrosis Indexes/Scores for the Screening of Cryptic Liver Fibrosis in Patients with NASH Risk Factors: A Case Report. Arch Hepat Res 2017;3:001-003. [DOI: 10.17352/ahr.000007] [Reference Citation Analysis]
166 Huang Y, Jeffrey GP, Adams LA. Hepascore and Its Application to Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_29] [Reference Citation Analysis]
167 Gressner AM, Gressner OA. Forns-Index. Lexikon der Medizinischen Laboratoriumsdiagnostik 2017. [DOI: 10.1007/978-3-662-49054-9_1162-1] [Reference Citation Analysis]
168 Gaur K, Sakhuja P, Puri AS, Majumdar K. Gluten-Free hepatomiracle in "celiac hepatitis": A case highlighting the rare occurrence of nutrition-induced near total reversal of advanced steatohepatitis and cirrhosis. Saudi J Gastroenterol 2016;22:461-4. [PMID: 27976643 DOI: 10.4103/1319-3767.195554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
169 Puigvehí M, Hernández J, Broquetas T, Coll S, Garcia-Retortillo M, Cañete N, Giménez MD, Garcia M, Bory F, Salvadó M, Solà R, Carrión JA. Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years. PLoS One 2016;11:e0164883. [PMID: 27984583 DOI: 10.1371/journal.pone.0164883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
170 Zhuang Y, Ding H, Zhang Y, Sun H, Xu C, Wang W. Two-dimensional Shear-Wave Elastography Performance in the Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis B: Comparison with Serum Fibrosis Indexes. Radiology. 2017;283:873-882. [PMID: 27982760 DOI: 10.1148/radiol.2016160131] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 11.1] [Reference Citation Analysis]
171 Lykiardopoulos B, Hagström H, Fredrikson M, Ignatova S, Stål P, Hultcrantz R, Ekstedt M, Kechagias S. Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms. PLoS One 2016;11:e0167776. [PMID: 27936091 DOI: 10.1371/journal.pone.0167776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
172 Karanjia RN, Crossey MME, Cox IJ, Fye HKS, Njie R, Goldin RD, Taylor-Robinson SD. Hepatic steatosis and fibrosis: Non-invasive assessment. World J Gastroenterol 2016; 22(45): 9880-9897 [PMID: 28018096 DOI: 10.3748/wjg.v22.i45.9880] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
173 [DOI: 10.1109/iccic.2016.7919541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
174 Meissner EG, McLaughlin M, Matthews L, Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D, Martens C, Porcella SF, Goodman ZD, Kanwar B, Myers RP, Subramanian M, Hadigan C, Masur H, Kleiner DE, Heller T, Kottilil S, Kovacs JA, Morse CG. Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial. Liver Int 2016;36:1783-92. [PMID: 27232579 DOI: 10.1111/liv.13177] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
175 Khattab M, Sakr MA, Fattah MA, Mousa Y, Soliman E, Breedy A, Fathi M, Gaber S, Altaweil A, Osman A, Hassouna A, Motawea I. Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patients. World J Hepatol 2016; 8(32): 1392-1401 [PMID: 27917265 DOI: 10.4254/wjh.v8.i32.1392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
176 Xiao G, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Yan L, Qin R. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma. Dig Liver Dis 2016;48:1220-6. [PMID: 27599803 DOI: 10.1016/j.dld.2016.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
177 Deng Y, Zhao H, Zhou J, Yan L, Wang G; China HepB-Related Fibrosis Assessment Research Group. Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus. Infection. 2017;45:75-81. [PMID: 27605044 DOI: 10.1007/s15010-016-0942-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
178 Sugimoto M, Oka H, Kajihama A, Nakau K, Kuwata S, Kurishima C, Azuma H. Non-invasive assessment of liver fibrosis by magnetic resonance elastography in patients with congenital heart disease undergoing the Fontan procedure and intracardiac repair. Journal of Cardiology 2016;68:202-8. [DOI: 10.1016/j.jjcc.2016.05.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
179 El-etreby S. Fibrosis 4 Score Versus Hyaluronic Acid as Non-Invasive Tools for Assessment of HCV-Related Hepatic Fibrosis: Correlation with Quantitative Morphometric Analysis of Liver Biopsy. GHOA 2016;5. [DOI: 10.15406/ghoa.2016.05.00134] [Reference Citation Analysis]
180 Kubo K, Kawakami H, Kuwatani M, Nishida M, Kawakubo K, Kawahata S, Taya Y, Kubota Y, Amano T, Shirato H, Sakamoto N. Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. BMC Gastroenterol 2016;16:65. [PMID: 27391646 DOI: 10.1186/s12876-016-0479-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
181 Chin JL, Pavlides M, Moolla A, Ryan JD. Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? Front Pharmacol. 2016;7:159. [PMID: 27378924 DOI: 10.3389/fphar.2016.00159] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
182 D'Ambrosio R, Degasperi E, Aghemo A, Fraquelli M, Lampertico P, Rumi MG, Facchetti F, Grassi E, Casazza G, Rosenberg W, Bedossa P, Colombo M. Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon. PLoS One 2016;11:e0155967. [PMID: 27304619 DOI: 10.1371/journal.pone.0155967] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
183 Kiani A, Brun V, Lainé F, Turlin B, Morcet J, Michalak S, Le Gruyer A, Legros L, Bardou-Jacquet E, Gandon Y, Moirand R. Acoustic radiation force impulse imaging for assessing liver fibrosis in alcoholic liver disease. World J Gastroenterol 2016; 22(20): 4926-4935 [PMID: 27239119 DOI: 10.3748/wjg.v22.i20.4926] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
184 Almpanis Z, Demonakou M, Tiniakos D. Evaluation of liver fibrosis: "Something old, something new…". Ann Gastroenterol 2016;29:445-53. [PMID: 27708509 DOI: 10.20524/aog.2016.0046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
185 Dong CF, Xiao J, Shan LB, Li HY, Xiong YJ, Yang GL, Liu J, Yao SM, Li SX, Le XH, Yuan J, Zhou BP, Tipoe GL, Liu YX. Combined acoustic radiation force impulse, aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B. World J Hepatol 2016; 8(14): 616-624 [PMID: 27190578 DOI: 10.4254/wjh.v8.i14.616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
186 Behairy BES, Sira MM, Zalata KR, Salama ESE, Abd-Allah MA. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? World J Gastroenterol 2016; 22(16): 4238-4249 [PMID: 27122674 DOI: 10.3748/wjg.v22.i16.4238] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
187 Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol. 2016;22:76-139. [PMID: 27044763 DOI: 10.3350/cmh.2016.22.1.76] [Cited by in Crossref: 49] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
188 Peters MG, Bacchetti P, Boylan R, French AL, Tien PC, Plankey MW, Glesby MJ, Augenbraun M, Golub ET, Karim R, Parkes J, Rosenberg W. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV. AIDS 2016;30:723-9. [PMID: 26595542 DOI: 10.1097/QAD.0000000000000975] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
189 Andrés-Otero MJ, De-Blas-Giral I, Puente-Lanzarote JJ, Serrano-Aulló T, Morandeira MJ, Lorente S, Lou-Bonafonte JM. Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients. Clin Biochem 2016;49:560-5. [PMID: 26968102 DOI: 10.1016/j.clinbiochem.2015.12.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
190 Stasi C, Leoncini L, Biagini MR, Arena U, Madiai S, Laffi G, Marra F, Milani S. Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry. Dig Liver Dis 2016;48:298-301. [PMID: 26632448 DOI: 10.1016/j.dld.2015.10.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
191 Touré PS, Diop MM, Lô G, Sow-sall A, Da Veiga JA, Sarr MM, Berthé A, Dioussé P, Ndiaye BP, Tall CT, Diop BM, Touré-kane NC, Ka MM, Mboup S. Intêret du FibroScan® et des marqueurs biologiques de la fibrose hépatique, chez des sénégalais porteurs chroniques du virus de l’hépatite B faiblement réplicatifs. J Afr Hepato Gastroenterol 2016;10:14-20. [DOI: 10.1007/s12157-015-0634-4] [Reference Citation Analysis]
192 Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH, Lee BW, Kang ES, Cha BS, Han KH. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology 2016;63:776-86. [PMID: 26638128 DOI: 10.1002/hep.28376] [Cited by in Crossref: 195] [Cited by in F6Publishing: 179] [Article Influence: 27.9] [Reference Citation Analysis]
193 Jiang ZG, Feldbrügge L, Tapper EB, Popov Y, Ghaziani T, Afdhal N, Robson SC, Mukamal KJ. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. Aliment Pharmacol Ther 2016;43:734-43. [PMID: 26749582 DOI: 10.1111/apt.13515] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
194 Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HLY, Irving WL, Sheridan D, Abate ML, Adams LA, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Nattermann J, Riordan S, Miele L, Kelaeng KS, Ampuero J, Ahlenstiel G, McLeod D, Powell E, Liddle C, Douglas MW, Booth DR, George J; International Liver Disease Genetics Consortium (ILDGC). FibroGENE: A gene-based model for staging liver fibrosis. J Hepatol 2016;64:390-8. [PMID: 26592354 DOI: 10.1016/j.jhep.2015.11.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
195 Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016; 22(4): 1367-1381 [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
196 Stasi C, Milani S. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. World J Gastroenterol 2016; 22(4): 1711-1720 [PMID: 26819535 DOI: 10.3748/wjg.v22.i4.1711] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
197 Hashem S, Esmat G, Elakel W, Habashy S, Abdel Raouf S, Darweesh S, Soliman M, Elhefnawi M, El-Adawy M, ElHefnawi M. Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients. Gastroenterol Res Pract 2016;2016:2636390. [PMID: 26880886 DOI: 10.1155/2016/2636390] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
198 Xiao G, Yan L. Liver Fibrosis and Its Assessment. Operative Techniques in Liver Resection 2016. [DOI: 10.1007/978-94-017-7411-6_5] [Reference Citation Analysis]
199 Goossens N, Clément S, Negro F. Diagnosis. Handbook of Hepatitis C 2016. [DOI: 10.1007/978-3-319-28053-0_5] [Reference Citation Analysis]
200 Thiele M, Detlefsen S, Sevelsted Møller L, Madsen BS, Fuglsang Hansen J, Fialla AD, Trebicka J, Krag A. Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis. Gastroenterology 2016;150:123-33. [PMID: 26435270 DOI: 10.1053/j.gastro.2015.09.040] [Cited by in Crossref: 149] [Cited by in F6Publishing: 152] [Article Influence: 21.3] [Reference Citation Analysis]
201 Bholee AK, Chen M. Diagnosis of Small Hepatocellular Carcinoma. Radiofrequency Ablation for Small Hepatocellular Carcinoma 2016. [DOI: 10.1007/978-94-017-7258-7_1] [Reference Citation Analysis]
202 Kliemann DA, Wolff FH, Tovo CV, Alencastro PR, Ikeda ML, Brandão AB, Barcellos N, Fuchs SC. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients. Ann Hepatol 2016;15:27-32. [PMID: 26626637 DOI: 10.5604/16652681.1184197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
203 Constantino ME. Naturaleza y grafía. El <em>corpus</em> documental de las colecciones animales en el Real Gabinete de Madrid, 1752-1790. Asclepio 2015;67:p110. [DOI: 10.3989/asclepio.2015.28] [Reference Citation Analysis]
204 Dhyani M, Anvari A, Samir AE. Ultrasound elastography: liver. Abdom Imaging 2015;40:698-708. [PMID: 25690689 DOI: 10.1007/s00261-015-0373-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
205 Deng H, Qi X, Peng Y, Li J, Li H, Zhang Y, Liu X, Sun X, Guo X. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit 2015;21:3961-77. [PMID: 26687574 DOI: 10.12659/msm.895005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
206 Rockey DC. Hepatic Fibrosis and Cirrhosis. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch105] [Reference Citation Analysis]
207 Arrayhani M, Sqalli T, Tazi N, El Youbi R, Chaouch S, Aqodad N, Ibrahimi SA. Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C. Pan Afr Med J 2015;22:273. [PMID: 26958136 DOI: 10.11604/pamj.2015.22.273.2311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
208 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 12.0] [Reference Citation Analysis]
209 Meng F, Zheng Y, Zhang Q, Mu X, Xu X, Zhang H, Ding L. Noninvasive evaluation of liver fibrosis using real-time tissue elastography and transient elastography (FibroScan). J Ultrasound Med. 2015;34:403-410. [PMID: 25715361 DOI: 10.7863/ultra.34.3.403] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
210 Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol 2015; 21(41): 11567-11583 [PMID: 26556987 DOI: 10.3748/wjg.v21.i41.11567] [Cited by in CrossRef: 165] [Cited by in F6Publishing: 177] [Article Influence: 20.6] [Reference Citation Analysis]
211 Kalafateli M, Gurusamy KS, Noel-storr AH, Burroughs AK, Tsochatzis E. Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis C. Cochrane Database of Systematic Reviews 2015. [DOI: 10.1002/14651858.cd011929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
212 Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol 2015; 21(39): 11044-11052 [PMID: 26494961 DOI: 10.3748/wjg.v21.i39.11044] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
213 Ivanescu AE, Li P, George B, Brown AW, Keith SW, Raju D, Allison DB. The importance of prediction model validation and assessment in obesity and nutrition research. Int J Obes (Lond) 2016;40:887-94. [PMID: 26449421 DOI: 10.1038/ijo.2015.214] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
214 Andrés-otero MJ, Lou-bonafonte JM, Escanero-marcén J, Serrano-aulló T, Puente-lanzarote JJ. Biomarcadores, índices y algoritmos para el diagnóstico de fibrosis hepática en pacientes con hepatitis crónica por virus C. Revista del Laboratorio Clínico 2015;8:179-187. [DOI: 10.1016/j.labcli.2015.07.004] [Reference Citation Analysis]
215 Bradley E, Hendrickson B, Daniels C. Fontan Liver Disease: Review of an Emerging Epidemic and Management Options. Curr Treat Options Cardiovasc Med 2015;17:51. [PMID: 26407544 DOI: 10.1007/s11936-015-0412-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
216 Cho Y, Tokuhara D, Morikawa H, Kuwae Y, Hayashi E, Hirose M, Hamazaki T, Tanaka A, Kawamura T, Kawada N. Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan. PLoS One. 2015;10:e0137239. [PMID: 26398109 DOI: 10.1371/journal.pone.0137239] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
217 Feng L, Sun K, Zhang J, Feng G, Zhao Y. A novel non-invasive index using AFP and APTT is associated with liver fibrosis in patients with chronic hepatitis B infection: a retrospective cohort study. BMJ Open 2015;5:e008032. [PMID: 26391629 DOI: 10.1136/bmjopen-2015-008032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
218 Shimizu M, Miyamoto K, Nishihara Y, Izumi G, Sakai S, Inai K, Nishikawa T, Nakanishi T. Risk factors and serological markers of liver cirrhosis after Fontan procedure. Heart Vessels 2016;31:1514-21. [PMID: 26386570 DOI: 10.1007/s00380-015-0743-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
219 Huang R, Yang CC, Liu Y, Xia J, Su R, Xiong YL, Wang GY, Sun ZH, Yan XM, Lu S, Wu C. Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients. World J Gastroenterol 2015; 21(34): 9957-9965 [PMID: 26379400 DOI: 10.3748/wjg.v21.i34.9957] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
220 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T, Tanaka J. Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index. J Gastroenterol 2016;51:380-9. [DOI: 10.1007/s00535-015-1117-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
221 Colecchia A, Marasco G, Taddia M, Montrone L, Eusebi LH, Mandolesi D, Schiumerini R, Di Biase AR, Festi D. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. Eur J Gastroenterol Hepatol 2015;27:992-1001. [PMID: 26020376 DOI: 10.1097/MEG.0000000000000393] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
222 Zhang Q, Xu M, Qu Y, Li Z, Zhang Q, Cai X, Lu L. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection. Mol Med Rep. 2015;12:5647-5654. [PMID: 26299203 DOI: 10.3892/mmr.2015.4221] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
223 Tachi Y, Hirai T, Toyoda H, Tada T, Hayashi K, Honda T, Ishigami M, Goto H, Kumada T. Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus. PLoS One 2015;10:e0133515. [PMID: 26214180 DOI: 10.1371/journal.pone.0133515] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
224 Cho EJ, Kim MY, Lee JH, Lee IY, Lim YL, Choi DH, Kim YJ, Yoon JH, Baik SK. Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis. PLoS One. 2015;10:e0133935. [PMID: 26196942 DOI: 10.1371/journal.pone.0133935] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
225 Salkic NN, Cickusic E, Jovanovic P, Denjagic MB, Iljazovic-Topcic S, Bevanda M, Ahmetagic S. Online combination algorithm for non-invasive assessment of chronic hepatitis B related liver fibrosis and cirrhosis in resource-limited settings. Eur J Intern Med. 2015;26:628-634. [PMID: 26194460 DOI: 10.1016/j.ejim.2015.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
226 Neuman MG, Cohen LB, Nanau RM. Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin Biochem. 2016;49:302-315. [PMID: 26188920 DOI: 10.1016/j.clinbiochem.2015.07.019] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
227 European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237-64. [PMID: 25911335 DOI: 10.1016/j.jhep.2015.04.006] [Cited by in Crossref: 1128] [Cited by in F6Publishing: 1122] [Article Influence: 141.0] [Reference Citation Analysis]
228 Yang M, Xu D, Liu Y, Guo X, Li W, Guo C, Zhang H, Gao Y, Mao Y, Zhao J. Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis. PLoS One. 2015;10:e0131664. [PMID: 26121037 DOI: 10.1371/journal.pone.0131664] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
229 Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(24): 7427-7435 [PMID: 26139988 DOI: 10.3748/wjg.v21.i24.7427] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
230 Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol 2015;110:857-64. [PMID: 25916223 DOI: 10.1038/ajg.2015.118] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 12.6] [Reference Citation Analysis]
231 Lückhoff HK, Kruger FC, Kotze MJ. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World J Hepatol 2015; 7(9): 1192-1208 [PMID: 26019735 DOI: 10.4254/wjh.v7.i9.1192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
232 Bota S, Paternostro R, Etschmaier A, Schwarzer R, Salzl P, Mandorfer M, Kienbacher C, Ferlitsch M, Reiberger T, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine. Ultrasound Med Biol. 2015;41:2340-2349. [PMID: 26004669 DOI: 10.1016/j.ultrasmedbio.2015.04.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
233 Musialik J, Jonderko K, Kasicka-Jonderko A, Buschhaus M. (13)CO2 breath tests in non-invasive hepatological diagnosis. Prz Gastroenterol 2015;10:1-6. [PMID: 25960807 DOI: 10.5114/pg.2014.47501] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
234 Alboraie M, Khairy M, Elsharkawy M, Asem N, Elsharkawy A, Esmat G. Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus. Hepatol Res 2015;45:560-70. [PMID: 24995544 DOI: 10.1111/hepr.12385] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
235 Simpson HN, McGuire BM. Screening and detection of hepatocellular carcinoma. Clin Liver Dis 2015;19:295-307. [PMID: 25921664 DOI: 10.1016/j.cld.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
236 Rao JG, Gao YF, Ye J, Wei YY, Li F, Zou GZ. Value of Forns index for noninvasive diagnosis of liver fibrosis in chronic hepatitis B patients. Shijie Huaren Xiaohua Zazhi 2015; 23(11): 1818-1824 [DOI: 10.11569/wcjd.v23.i11.1818] [Reference Citation Analysis]
237 Enomoto H, Aizawa N, Nakamura H, Takata R, Sakai Y, Iwata Y, Tanaka H, Ikeda N, Aoki T, Hasegawa K, Yoh K, Hashimoto K, Ishii A, Takashima T, Saito M, Imanishi H, Iijima H, Nishiguchi S. A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. Gastroenterol Res Pract 2015;2015:926169. [PMID: 25861264 DOI: 10.1155/2015/926169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
238 Park SH, Bang CS, Kim DJ. Biomarkers in HCV Infection. Adv Clin Chem 2015;70:131-96. [PMID: 26231487 DOI: 10.1016/bs.acc.2015.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
239 Abe T, Hashiguchi A, Yamazaki K, Ebinuma H, Saito H, Kumada H, Izumi N, Masaki N, Sakamoto M. Quantification of collagen and elastic fibers using whole-slide images of liver biopsy specimens. Pathol Int. 2013;63:305-310. [PMID: 23782332 DOI: 10.1111/pin.12064] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
240 Romero-Gómez M, Turnes J, Ampuero J, Oyagüez I, Cuenca B, Gonzalez-Garcia J, Muñoz-Molina B, Aguilar R, Leal S, Planas R, Garcia-Samaniego J, Diago M, Crespo J, Calleja JL, Casado MA, Sola R. Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study. PLoS One 2015;10:e0122613. [PMID: 25826755 DOI: 10.1371/journal.pone.0122613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
241 Alboraie M, Khairy M, Elsharkawy A, Elsharkawy M, Asem N, Abo El-Seoud AR, Elghamry FG, Esmat G. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach. Saudi J Gastroenterol. 2014;20:170-174. [PMID: 24976280 DOI: 10.4103/1319-3767.133003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
242 Saito M, Yano Y, Hirano H, Momose K, Yoshida M, Azuma T. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C. Hepat Mon 2015;15:e22978. [PMID: 25788955 DOI: 10.5812/hepatmon.22978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
243 Dong DR, Hao MN, Li C, Peng Z, Liu X, Wang GP, Ma AL. Acoustic radiation force impulse elastography, FibroScan®, Forns’ index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods. Mol Med Rep. 2015;11:4174-4182. [PMID: 25651500 DOI: 10.3892/mmr.2015.3299] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
244 Shaheen AAM, Myers RP. Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection. HIV Clinical Trials 2015;9:43-51. [DOI: 10.1310/hct0901-43] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
245 Padoan A, Bernardi D, Plebani M. Biomarker Panels and Multiple Readouts. Principles of Translational Science in Medicine 2015. [DOI: 10.1016/b978-0-12-800687-0.00017-7] [Reference Citation Analysis]
246 Soresi M, Giannitrapani L, Cervello M, Licata A, Montalto G. Non invasive tools for the diagnosis of liver cirrhosis. World J Gastroenterol 2014; 20(48): 18131-18150 [PMID: 25561782 DOI: 10.3748/wjg.v20.i48.18131] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
247 Nojiri S, Fujiwara K, Shinkai N, Endo M, Joh T. Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI. World J Hepatol 2014; 6(12): 930-938 [PMID: 25544880 DOI: 10.4254/wjh.v6.i12.930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
248 Cho HJ, Kim SS, Ahn SJ, Park JH, Kim DJ, Kim YB, Cho SW, Cheong JY. Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B. Clin Mol Hepatol. 2014;20:347-354. [PMID: 25548740 DOI: 10.3350/cmh.2014.20.4.347] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
249 Berenguer J, Zamora FX, Aldámiz-echevarría T, Von Wichmann MA, Crespo M, López-aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-pellicer J, Esteban H, Bellón JM, González-garcía J, Miralles P, Cosín J, López J, Padilla B, Parras F, Carrero A, Aldamiz-echevarría T, Tejerina F, Gutiérrez I, Ramírez M, Carretero S, Bellón J, Berenguer J, Alvarez-pellicer J, Rodríguez E, Arribas J, Montes M, Bernardino I, Pascual J, Zamora F, Peña J, Arnalich F, Díaz M, González-garcía J, Bustinduy M, Iribarren J, Rodríguez-arrondo F, Von-wichmann M, Blanes M, Cuellar S, Lacruz J, Montero M, Salavert M, López-aldeguer J, Callau P, Miró J, Gatell J, Mallolas J, Ferrer A, Galindo M, Van den Eynde E, Pérez M, Ribera E, Crespo M, Vergas J, Téllez M, Casado J, Dronda F, Moreno A, Pérez-elías M, Sanfrutos M, Moreno S, Quereda C, Jou A, Tural C, Arranz A, Casas E, de Miguel J, Schroeder S, Sanz J, Condés E, Barros C, Sanz J, Santos I, Hernando A, Rodríguez V, Rubio R, Pulido F, Domingo P, Guardiola J, Ortiz L, Ortega E, Torres R, Cervero M, Jusdado J, Rodríguez-zapata M, Pérez G, Gaspar G, Barquilla E, Ramírez M, Moyano B, Aznar E, Esteban H; for the Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group. Comparison of the Prognostic Value of Liver Biopsy and FIB-4 Index in Patients Coinfected With HIV and Hepatitis C Virus. Clinical Infectious Diseases 2015;60:950-8. [DOI: 10.1093/cid/ciu939] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
250 Ardoino I, Lanzoni M, Marano G, Boracchi P, Sagrini E, Gianstefani A, Piscaglia F, Biganzoli EM. Widen NomoGram for multinomial logistic regression: an application to staging liver fibrosis in chronic hepatitis C patients. Stat Methods Med Res 2017;26:823-38. [PMID: 25413994 DOI: 10.1177/0962280214560045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
251 Wong GL. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 2014;20:228-36. [PMID: 25320725 DOI: 10.3350/cmh.2014.20.3.228] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
252 Enomoto M, Morikawa H, Tamori A, Kawada N. Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2014; 20(34): 12031-12038 [PMID: 25232240 DOI: 10.3748/wjg.v20.i34.12031] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
253 Cassinotto C, Lapuyade B, Mouries A, Hiriart JB, Vergniol J, Gaye D, Castain C, Le Bail B, Chermak F, Foucher J, Laurent F, Montaudon M, De Ledinghen V. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®. J Hepatol 2014;61:550-7. [PMID: 24815876 DOI: 10.1016/j.jhep.2014.04.044] [Cited by in Crossref: 241] [Cited by in F6Publishing: 242] [Article Influence: 26.8] [Reference Citation Analysis]
254 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 143] [Cited by in F6Publishing: 148] [Article Influence: 15.9] [Reference Citation Analysis]
255 Cha SW, Jeong WK, Kim Y, Kim MY, Kim J, Kim SY, Ryu JA, Kim TY, Sohn JH, Kim YH. Nondiseased liver stiffness measured by shear wave elastography: a pilot study. J Ultrasound Med 2014;33:53-60. [PMID: 24371099 DOI: 10.7863/ultra.33.1.53] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
256 Rao PN. Nodule in Liver: Investigations, Differential Diagnosis and Follow-up. J Clin Exp Hepatol 2014;4:S57-62. [PMID: 25755612 DOI: 10.1016/j.jceh.2014.06.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
257 Silva Junior RG, Schmillevitch J, Nascimento Mde F, Miranda ML, Brant PE, Schulz PO, Vieira A, Szutan LA. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C. Scand J Gastroenterol 2014;49:986-92. [PMID: 24742130 DOI: 10.3109/00365521.2014.909528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
258 Zeng DW, Zhang JM, Liu YR, Dong J, Wu YL, Lin S, Jiang JJ, Zhu YY. A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity. Clin Res Hepatol Gastroenterol. 2014;38:727-734. [PMID: 25048838 DOI: 10.1016/j.clinre.2014.06.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
259 Chrostek L, Panasiuk A. Liver fibrosis markers in alcoholic liver disease. World J Gastroenterol 2014; 20(25): 8018-8023 [PMID: 25009372 DOI: 10.3748/wjg.v20.i25.8018] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
260 Yilmaz B, Basar O, Altınbas A, Ekiz F, Aktas B, Oztürk G, Ginis Z, Coban S, Ucar E, Erarslan E, Coskun Y, Yüksel I, Tuna Y, Yüksel O. The utility of thrombopoietin in predicting liver fibrosis in chronic hepatitis B. Int J Clin Exp Med 2014;7:1430-4. [PMID: 24995107] [Reference Citation Analysis]
261 Zeremski M, Dimova RB, Benjamin S, Makeyeva J, Yantiss RK, Gambarin-Gelwan M, Talal AH. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B. BMC Gastroenterol 2014;14:118. [PMID: 24990385 DOI: 10.1186/1471-230X-14-118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
262 Vergniol J, Boursier J, Coutzac C, Bertrais S, Foucher J, Angel C, Chermak F, Hubert IF, Merrouche W, Oberti F, de Lédinghen V, Calès P. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology 2014;60:65-76. [PMID: 24519328 DOI: 10.1002/hep.27069] [Cited by in Crossref: 103] [Cited by in F6Publishing: 79] [Article Influence: 11.4] [Reference Citation Analysis]
263 Cequera A, García de León Méndez M. Biomarkers for liver fibrosis: Advances, advantages and disadvantages. Revista de Gastroenterología de México (English Edition) 2014;79:187-99. [DOI: 10.1016/j.rgmxen.2014.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
264 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol 2014;20:89-136. [PMID: 25032178 DOI: 10.3350/cmh.2014.20.2.89] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
265 Cequera A, García de León Méndez MC. [Biomarkers for liver fibrosis: advances, advantages and disadvantages]. Rev Gastroenterol Mex 2014;79:187-99. [PMID: 24954541 DOI: 10.1016/j.rgmx.2014.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
266 Pár G, Trosits A, Pakodi F, Szabó I, Czimmer J, Illés A, Gódi S, Bajor J, Sarlós P, Kenyeres P, Miseta A, Vincze A, Pár A. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis]. Orv Hetil 2014;155:270-6. [PMID: 24509356 DOI: 10.1556/OH.2014.29824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
267 Suk KT, Kim DY, Sohn KM, Kim DJ. Biomarkers of liver fibrosis. Adv Clin Chem 2013;62:33-122. [PMID: 24772665 DOI: 10.1016/b978-0-12-800096-0.00002-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
268 Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Bello BD, Filice G, Filice C. Point shear wave elastography method for assessing liver stiffness. World J Gastroenterol 2014; 20(16): 4787-4796 [PMID: 24782633 DOI: 10.3748/wjg.v20.i16.4787] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 96] [Article Influence: 10.8] [Reference Citation Analysis]
269 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 74] [Article Influence: 7.9] [Reference Citation Analysis]
270 Saludes V, González V, Planas R, Matas L, Ausina V, Martró E. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging. World J Gastroenterol 2014; 20(13): 3431-3442 [PMID: 24707126 DOI: 10.3748/wjg.v20.i13.3431] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
271 Schiavon LL, Narciso-Schiavon JL, Carvalho-Filho RJ. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol 2014; 20(11): 2854-2866 [PMID: 24659877 DOI: 10.3748/wjg.v20.i11.2854] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
272 Kang W, Kim SU, Ahn SH. Non-invasive prediction of forthcoming cirrhosis-related complications. World J Gastroenterol 2014; 20(10): 2613-2623 [PMID: 24627597 DOI: 10.3748/wjg.v20.i10.2613] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
273 Toshima T, Shirabe K, Ikegami T, Yoshizumi T, Kuno A, Togayachi A, Gotoh M, Narimatsu H, Korenaga M, Mizokami M, Nishie A, Aishima S, Maehara Y. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol. 2015;50:76-84. [PMID: 24603981 DOI: 10.1007/s00535-014-0946-y] [Cited by in Crossref: 129] [Cited by in F6Publishing: 135] [Article Influence: 14.3] [Reference Citation Analysis]
274 Takaki S, Kawakami Y, Miyaki D, Nakahara T, Naeshiro N, Murakami E, Tanaka M, Honda Y, Yokoyama S, Nagaoki Y, Kawaoka T, Hiramatsu A, Tsuge M, Hiraga N, Imamura M, Hyogo H, Aikata H, Takahashi S, Arihiro K, Chayama K. Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients. Hepatol Res 2014;44:280-7. [PMID: 23607728 DOI: 10.1111/hepr.12129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
275 Enomoto H, Aizawa N, Nakamura H, Sakai Y, Iwata Y, Tanaka H, Ikeda N, Aoki T, Yuri Y, Yoh K. An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients. Gastroenterol Res Pract. 2014;2014:351396. [PMID: 24693282 DOI: 10.1155/2014/351396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
276 Nishikawa T, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Mizuno Y, Shimazaki H, Kan T, Nakaoka K, Takagawa Y, Ohki M, Ichino N, Osakabe K, Yoshioka K. Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C. World J Gastroenterol 2014; 20(5): 1289-1297 [PMID: 24574802 DOI: 10.3748/wjg.v20.i5.1289] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
277 Maieron A, Salzl P, Peck-Radosavljevic M, Trauner M, Hametner S, Schöfl R, Ferenci P, Ferlitsch M. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther 2014;39:331-8. [PMID: 24308724 DOI: 10.1111/apt.12564] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
278 Ozkurt H, Keskiner F, Karatag O, Alkim C, Erturk SM, Basak M. Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol 2014;11:e3555. [PMID: 24693297 DOI: 10.5812/iranjradiol.3555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
279 Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Scand J Clin Lab Invest. 2014;74:240-247. [PMID: 24460024 DOI: 10.3109/00365513.2013.879392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
280 Wong GL, Chan HL, Choi PC, Chan AW, Yu Z, Lai JW, Chan HY, Wong VW. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2014;39:197-208. [PMID: 24261924 DOI: 10.1111/apt.12559] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
281 Hassan EM, Omran DA, El Beshlawey ML, Abdo M, El Askary A. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients? Gastroenterol Hepatol. 2014;37:58-65. [PMID: 24365388 DOI: 10.1016/j.gastrohep.2013.09.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
282 Crespo G, Forns X, Navasa M. [Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation]. Gastroenterol Hepatol 2012;35 Suppl 2:17-22. [PMID: 23298655 DOI: 10.1016/S0210-5705(12)70045-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
283 Tamaki N, Kurosaki M, Matsuda S, Muraoka M, Yasui Y, Suzuki S, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Asahina Y, Izumi N. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. J Gastroenterol. 2014;49:1495-1503. [PMID: 24337828 DOI: 10.1007/s00535-013-0914-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
284 Gavilán JC, Ojeda G, Arnedo R, Puerta S. Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C. European Journal of Internal Medicine 2013;24:846-51. [DOI: 10.1016/j.ejim.2013.06.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
285 Gabr SA, Alghadir AH. Prediction of fibrosis in hepatitis C patients: assessment using hydroxyproline and oxidative stress biomarkers. Virusdisease 2014;25:91-100. [PMID: 24426315 DOI: 10.1007/s13337-013-0182-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
286 Cao Y, Hu ZD, Liu XF, Deng AM, Hu CJ. An MLP classifier for prediction of HBV-induced liver cirrhosis using routinely available clinical parameters. Dis Markers 2013;35:653-60. [PMID: 24302810 DOI: 10.1155/2013/127962] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
287 Hayashi T, Inuzuka R, Shindo T, Hirata Y, Shimizu N, Oka A. Serum Hyaluronic Acid Concentration in Fontan Circulation: Correlation With Hepatic Function and Portal Vein Hemodynamics. Pediatr Cardiol 2014;35:608-15. [DOI: 10.1007/s00246-013-0827-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
288 Wan R, Liu H, Wan G, Wang X, Zhou G, Jiang Y, Sun F, Yang Z, Wang X. WITHDRAWN: Noninvasive predictive models of liver fibrosis in patients with chronic hepatitis B. Journal of Surgical Research 2013. [DOI: 10.1016/j.jss.2013.10.034] [Reference Citation Analysis]
289 Xu MY, Jia XF, Qu Y, Zheng RD, Yuan ZH, Weng HL, Dooley S, Wang XP, Zhang LJ, Lu LG. Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B. J Transl Med. 2013;11:234. [PMID: 24289155 DOI: 10.1186/1479-5876-11-234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
290 Xu M, Qu Y, Jia X, Wang M, Liu H, Wang X, Zhang L, Lu L. Serum proteomic MRM identify peptide ions of transferrin as new fibrosis markers in chronic hepatitis B. Biomedicine & Pharmacotherapy 2013;67:561-7. [DOI: 10.1016/j.biopha.2013.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
291 Saludes V, Bascuñana E, Jordana-Lluch E, Casanovas S, Ardèvol M, Soler E, Planas R, Ausina V, Martró E. Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients. PLoS One 2013;8:e72600. [PMID: 24015264 DOI: 10.1371/journal.pone.0072600] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
292 Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta I, Draguţ R, Parpala C, Nan R, Sima I, Ateia S, Stoica V, Cheţa DM, Radulian G. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial. Nutr J 2013;12:119. [PMID: 23941362 DOI: 10.1186/1475-2891-12-119] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
293 Lens S, Forns X. Utilidad de la elastografía de transición tras la respuesta virológica en la hepatitis crónica por el virus de la hepatitisC. Enfermedades Infecciosas y Microbiología Clínica 2013;31:421-423. [DOI: 10.1016/j.eimc.2013.04.008] [Reference Citation Analysis]
294 Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 2013;59:236-42. [PMID: 23523583 DOI: 10.1016/j.jhep.2013.03.016] [Cited by in Crossref: 204] [Cited by in F6Publishing: 202] [Article Influence: 20.4] [Reference Citation Analysis]
295 Castera L. Natural History of Chronic HCV Infection and Non-Invasive Assessment of Hepatic Fibrosis. Viral Hepatitis 2013. [DOI: 10.1002/9781118637272.ch23] [Reference Citation Analysis]
296 Hernández-Bartolomé A, López-Rodríguez R, Rodríguez-Muñoz Y, Martín-Vílchez S, Borque MJ, García-Buey L, González-Moreno L, Real Y, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link. PLoS One 2013;8:e66143. [PMID: 23823085 DOI: 10.1371/journal.pone.0066143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
297 Alboraie MA, Afifi ME, Elghamry FG, Shalaby HA, Elshennawy GE, Abdelaziz AA, Shaheen MU, Abo El-Seoud AR. Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study. Hepat Mon 2013;13:e10810. [PMID: 24046790 DOI: 10.5812/hepatmon.10810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
298 Wong GLH. Transient elastography: Kill two birds with one stone? World J Hepatol 2013; 5(5): 264-274 [PMID: 23717737 DOI: 10.4254/wjh.v5.i5.264] [Cited by in Crossref: 62] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
299 Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2013;7:356-68. [PMID: 26201770 DOI: 10.1007/s12072-013-9439-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
300 Gentile I, Coppola N, Pasquale G, Liuzzi R, D'Armiento M, Di Lorenzo ME, Capoluongo N, Buonomo AR, Sagnelli E, Morisco F, Caporaso N, Borgia G. A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C. Hepat Mon 2013;13:e8352. [PMID: 23967022 DOI: 10.5812/hepatmon.8352] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
301 Everhart JE, Wright EC. Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology 2013;57:1725-33. [PMID: 23258530 DOI: 10.1002/hep.26203] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
302 Wang Y, Xu MY, Zheng RD, Xian JC, Xu HT, Shi JP, Li SB, Qu Y, Dong YW, Lu LG. Prediction of significant fibrosis and cirrhosis in hepatitis B e-antigen negative patients with chronic hepatitis B using routine parameters. Hepatol Res 2013;43:441-51. [PMID: 23006433 DOI: 10.1111/j.1872-034X.2012.01094.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
303 de Lédinghen V, Vergniol J, Barthe C, Foucher J, Chermak F, Le Bail B, Merrouche W, Bernard PH. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther 2013;37:979-88. [PMID: 23557139 DOI: 10.1111/apt.12307] [Cited by in Crossref: 80] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
304 Bhogal H, Sterling RK. Staging of liver disease: which option is right for my patient? Infect Dis Clin North Am. 2012;26:849-861. [PMID: 23083819 DOI: 10.1016/j.idc.2012.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
305 Ikebuchi Y, Ishida C, Okamoto K, Murawaki Y. Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type C chronic liver disease. Biochem Genet. 2013;51:564-574. [PMID: 23563628 DOI: 10.1007/s10528-013-9587-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
306 Wong GL. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf) 2013;1:19-26. [PMID: 24759663 DOI: 10.1093/gastro/got007] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 6.3] [Reference Citation Analysis]
307 Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. PLoS One 2013;8:e59088. [PMID: 23555619 DOI: 10.1371/journal.pone.0059088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
308 Zarski JP, Sturm N, Guechot J, Zafrani ES, Vaubourdolle M, Thoret S, Margier J, David-Tchouda S, Bosson JL. Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C. PLoS One. 2013;8:e59088. [PMID: 23555619 DOI: 10.1371/journal.pone.0059088.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Erdogan S, Dogan HO, Sezer S, Uysal S, Ozhamam E, Kayacetin S, Koca Y. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients. Scand J Clin Lab Invest. 2013;73:300-308. [PMID: 23514016 DOI: 10.3109/00365513.2013.773592] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
310 Attallah AM, El-Far M, Omran MM, Farid K, Albannan MS, El-Dosoky I. Noninvasive diagnosis of liver fibrosis and cirrhosis in chronic hepatitis C patients. J Clin Lab Anal 2013;27:121-9. [PMID: 23460258 DOI: 10.1002/jcla.21572] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
311 Wu YM, Xu N, Hu JY, Xu XF, Wu WX, Gao SX, Zhu WJ, Wu WL, Shen XZ, Wang JY, Wu SD. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica. Parasitol Int 2013;62:283-8. [PMID: 23466574 DOI: 10.1016/j.parint.2013.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
312 Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation. SASLT practice guidelines: management of hepatitis C virus infection. Saudi J Gastroenterol 2012;18 Suppl:S1-32. [PMID: 23006491 DOI: 10.4103/1319-3767.101155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
313 Fujimoto K, Kato M, Kudo M, Yada N, Shiina T, Ueshima K, Yamada Y, Ishida T, Azuma M, Yamasaki M. Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis C. Oncology. 2013;84 Suppl 1:3-12. [PMID: 23428852 DOI: 10.1159/000345883] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
314 Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:85-91. [PMID: 23451000 DOI: 10.3238/arztebl.2013.0085] [Cited by in Crossref: 23] [Cited by in F6Publishing: 61] [Article Influence: 2.3] [Reference Citation Analysis]
315 Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. Clin Res Hepatol Gastroenterol 2013;37:152-8. [PMID: 23391746 DOI: 10.1016/j.clinre.2012.07.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
316 Gonzalez HC, Jafri SM, Gordon SC. Role of Liver Biopsy in the Era of Direct-Acting Antivirals. Curr Gastroenterol Rep 2013;15. [DOI: 10.1007/s11894-012-0307-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
317 Valva P, Casciato P, Lezama C, Galoppo M, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. PLoS One. 2013;8:e53519. [PMID: 23326448 DOI: 10.1371/journal.pone.0053519] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
318 Barrault C, Roudot-Thoraval F, Tran Van Nhieu J, Atanasiu C, Kluger MD, Medkour F, Douvin C, Mallat A, Zafrani ES, Cherqui D, Duvoux C. Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation. Clin Res Hepatol Gastroenterol. 2013;37:347-352. [PMID: 23318116 DOI: 10.1016/j.clinre.2012.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
319 Chen J, Liu C, Chen H, Liu Q, Yang B, Ou Q. Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation. J Clin Lab Anal. 2013;27:5-11. [PMID: 23292737 DOI: 10.1002/jcla.21554] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
320 El-mezayen HA, Toson el-SA, Shiha GE. Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 2013;25:69-76. [PMID: 23011038 DOI: 10.1097/MEG.0b013e3283594924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
321 Gressner AM, Arndt T. F. Lexikon der Medizinischen Laboratoriumsdiagnostik 2013. [DOI: 10.1007/978-3-642-12921-6_6] [Reference Citation Analysis]
322 Sheron N, Moore M, Ansett S, Parsons C, Bateman A. Developing a ‘traffic light’ test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community. Br J Gen Pract. 2012;62:e616-e624. [PMID: 22947582 DOI: 10.3399/bjgp12x654588] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
323 Bräu N. Evaluation of the hepatitis C virus-infected patient: the initial encounter. Clin Infect Dis. 2013;56:853-860. [PMID: 23243172 DOI: 10.1093/cid/cis957] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
324 Resino S, Sánchez-Conde M, Berenguer J. Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis. Curr Opin Infect Dis. 2012;25:564-569. [PMID: 22744318 DOI: 10.1097/qco.0b013e32835635df] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
325 Holmes JA, Thompson AJ, Adams LA. Biomarkers of Fibrosis and Fibrosis Progression in Chronic Hepatitis C. Curr Hepatitis Rep 2012;11:231-242. [DOI: 10.1007/s11901-012-0148-0] [Reference Citation Analysis]
326 Caballería L, Torán P. Detección precoz de la enfermedad hepática crónica en población adulta aparentemente sana en atención primaria. Gastroenterología y Hepatología 2012;35:23-9. [DOI: 10.1016/s0210-5705(12)70046-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
327 Fernández-varo G. Marcadores serológicos de fibrosis. Gastroenterología y Hepatología 2012;35:10-6. [DOI: 10.1016/s0210-5705(12)70044-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
328 Güzelbulut F, Sezikli M, Cetinkaya ZA, Ozkara S, Gönen C, Ovünç AO. A lower serum gamma-glutamyltransferase level does not predict a sustained virological response in patients with chronic hepatitis C genotype 1. Gut Liver. 2013;7:74-81. [PMID: 23423958 DOI: 10.5009/gnl.2013.7.1.74] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
329 Hernández-Guerra M, González-Méndez Y, de Molina P, Gimeno-García AZ, Carrillo M, Casanova C, Pumarola T, Jimenez A, Hernández-Porto M, Torres A, Quintero E. Immunogenicity and acceptance of influenza A (H1N1) vaccine in a cohort of chronic hepatitis C patients receiving pegylated-interferon treatment. PLoS One 2012;7:e48610. [PMID: 23144908 DOI: 10.1371/journal.pone.0048610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
330 Matsuda K, Ohsaki M, Katagiri S, Yokoi H, Takabayashi K. Application of kernel logistic regression to the prediction of liver fibrosis stages in chronic hepatitis C. The 6th International Conference on Soft Computing and Intelligent Systems, and The 13th International Symposium on Advanced Intelligence Systems 2012. [DOI: 10.1109/scis-isis.2012.6505161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
331 Zhu CL, Li WT, Li Y, Gao RT. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B. J Dig Dis 2012;13:558-63. [PMID: 23107442 DOI: 10.1111/j.1751-2980.2012.00629.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
332 Grünhage F, Hochrath K, Krawczyk M, Höblinger A, Obermayer-Pietsch B, Geisel J, Trauner M, Sauerbruch T, Lammert F. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012;56:1883-91. [PMID: 22576297 DOI: 10.1002/hep.25830] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
333 Karlas T, Hempel M, Tröltzsch M, Huster D, Günther P, Tenckhoff H, Mössner J, Berg T, Keim V, Wiegand J. Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores. Scand J Gastroenterol 2012;47:1353-61. [PMID: 22943453 DOI: 10.3109/00365521.2012.719924] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
334 [DOI: 10.1109/tencon.2012.6412222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
335 Trifan A, Stanciu C. Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol 2012; 18(39): 5514-5520 [PMID: 23112543 DOI: 10.3748/wjg.v18.i39.5514] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
336 Martinez SM, Foucher J, Combis JM, Métivier S, Brunetto M, Capron D, Bourlière M, Bronowicki JP, Dao T, Maynard-Muet M, Lucidarme D, Merrouche W, Forns X, de Lédinghen V. Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy. PLoS One 2012;7:e47715. [PMID: 23082200 DOI: 10.1371/journal.pone.0047715] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
337 Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Iwai T. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol. 2012;4:11-17. [PMID: 22312451 DOI: 10.5754/hge12064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
338 Suárez-Zarracina T, Valle-Garay E, Collazos J, Montes AH, Cárcaba V, Carton JA, Asensi V. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients. J Viral Hepat 2012;19:685-93. [PMID: 22967099 DOI: 10.1111/j.1365-2893.2012.01596.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
339 Ito K, Kuno A, Ikehara Y, Sugiyama M, Saito H, Aoki Y, Matsui T, Imamura M, Korenaga M, Murata K, Masaki N, Tanaka Y, Hige S, Izumi N, Kurosaki M, Nishiguchi S, Sakamoto M, Kage M, Narimatsu H, Mizokami M. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients. Hepatology 2012;56:1448-56. [PMID: 22535703 DOI: 10.1002/hep.25815] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
340 Francque SM, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Michielsen P, Van Gaal L. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol 2012;10:1162-8; quiz e87. [PMID: 22796457 DOI: 10.1016/j.cgh.2012.06.019] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
341 Myers RP, Ramji A, Bilodeau M, Wong S, Feld JJ. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol 2012;26:359-75. [PMID: 22720279 DOI: 10.1155/2012/947676] [Cited by in Crossref: 43] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
342 Miyashita M, Ito T, Sakaki M, Kajiwara A, Nozawa H, Hiroishi K, Kobayashi M, Kumada H, Imawari M. Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C. J Viral Hepat 2012;19:608-14. [PMID: 22863264 DOI: 10.1111/j.1365-2893.2011.01580.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
343 Crespo G, Fernández-Varo G, Mariño Z, Casals G, Miquel R, Martínez SM, Gilabert R, Forns X, Jiménez W, Navasa M. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. J Hepatol 2012;57:281-7. [PMID: 22521355 DOI: 10.1016/j.jhep.2012.03.016] [Cited by in Crossref: 116] [Cited by in F6Publishing: 124] [Article Influence: 10.5] [Reference Citation Analysis]
344 Kim BK, Kim HS, Park JY, Kim DY, Ahn SH, Chon CY, Park YN, Han KH, Kim SU. Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One. 2012;7:e41964. [PMID: 22848675 DOI: 10.1371/journal.pone.0041964] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
345 Karlas T, Neuschulz M, Oltmanns A, Güttler A, Petroff D, Wirtz H, Mainz JG, Mössner J, Berg T, Tröltzsch M, Keim V, Wiegand J. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores. PLoS One 2012;7:e42139. [PMID: 22848732 DOI: 10.1371/journal.pone.0042139] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
346 Du D, Zhu X, Kuno A, Matsuda A, Tsuruno C, Yu D, Zhang Y, Ikehara Y, Tanaka Y, Zhang X. Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels. Clin Chim Acta. 2012;413:1796-1799. [PMID: 22796373 DOI: 10.1016/j.cca.2012.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
347 Hshiao MH, Chen PC, Jao JC, Huang YH, Lee CC, Chao SY, Lin LW, Chen TB. Quantifying liver cirrhosis by extracting significant features from MRI T2 image. ScientificWorldJournal. 2012;2012:343847. [PMID: 22778696 DOI: 10.1100/2012/343847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
348 Liu XD, Wu JL, Liang J, Zhang T, Sheng QS. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol 2012; 18(22): 2784-2792 [PMID: 22719186 DOI: 10.3748/wjg.v18.i22.2784] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
349 Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293-1302.e4. [PMID: 22537436 DOI: 10.1053/j.gastro.2012.02.017] [Cited by in Crossref: 436] [Cited by in F6Publishing: 463] [Article Influence: 39.6] [Reference Citation Analysis]
350 Aoufi Rabih S, García Agudo R, Tenías Burillo JM, Ruiz Carrillo F, González Carro P, Pérez Roldán F, Ynfante Ferrús M, Bernardos Martín E, Roncero García-escribano Ó, Legaz Huidobro ML, Sánchez-manjavacas N. Microalbuminuria e insuficiencia renal en la infección crónica por el virus de la hepatitis C. Gastroenterología y Hepatología 2012;35:309-16. [DOI: 10.1016/j.gastrohep.2012.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
351 Kim BK, Kim SU, Kim HS, Park JY, Ahn SH, Chon CY, Cho IR, Joh DH, Park YN, Han KH, Kim DY. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One. 2012;7:e35825. [PMID: 22536445 DOI: 10.1371/journal.pone.0035825] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
352 Yang HR, Kim HR, Kim MJ, Ko JS, Seo JK. Noninvasive Parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18(13): 1525-1530 [PMID: 22509085 DOI: 10.3748/wjg.v18.i13.1525] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
353 Jafri SR, Gordon SC. Is there still a role for liver biopsy in managing hepatitis C virus infections? Clin Liver Dis (Hoboken) 2012;1:32-5. [PMID: 31186843 DOI: 10.1002/cld.30] [Reference Citation Analysis]
354 Radiology Quiz. An International Journal Clinical Rhinology 2012;5:53-53. [DOI: 10.5005/jp-journals-10013-1121] [Reference Citation Analysis]
355 Rocco A, de Nucci G, Valente G, Compare D, D'Arienzo A, Cimino L, Perri F, Nardone G. 13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C. J Hepatol 2012;56:782-7. [PMID: 22173159 DOI: 10.1016/j.jhep.2011.10.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
356 Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal NH, Thomas DL. Stability of liver fibrosis among HCV-infected injection drug users. Antivir Ther 2012;17:813-21. [PMID: 22418880 DOI: 10.3851/IMP2085] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
357 Crisan D, Radu C, Lupsor M, Sparchez Z, Grigorescu MD, Grigorescu M. Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients. Hepat Mon 2012;12:177-84. [PMID: 22550525 DOI: 10.5812/hepatmon.853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
358 Yoshioka K, Hashimoto S. Can non-invasive assessment of liver fibrosis replace liver biopsy? Hepatol Res 2012;42:233-40. [PMID: 22151829 DOI: 10.1111/j.1872-034X.2011.00928.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
359 Crisan D, Radu C, Lupsor M, Sparchez Z, Grigorescu MD, Grigorescu M. Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients. Hepat Mon 2012;12:177-84. [PMID: 22550525 DOI: 10.5812/hepatmon.853] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
360 Hsieh YY, Tung SY, Lee K, Wu CS, Wei KL, Shen CH, Chang TS, Lin YH. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gastroenterol 2012; 18(8): 746-753 [PMID: 22371634 DOI: 10.3748/wjg.v18.i8.746] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
361 Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H. Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels. Hepat Mon 2012;12:77-84. [PMID: 22509183 DOI: 10.5812/hepatmon.829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
362 Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Iwai T, Moriwaki EI, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol 2012; 4(1): 11-17 [PMID: 22312451 DOI: 10.4254/wjh.v4.i1.11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
363 Smith JO, Sterling RK. Noninvasive Markers of Liver Injury and Fibrosis. HIV and Liver Disease 2012. [DOI: 10.1007/978-1-4419-1712-6_5] [Reference Citation Analysis]
364 Vetter D, Friedman SL. Liver fibrogenesis. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract 2012. [DOI: 10.1016/b978-1-4377-1454-8.00006-0] [Reference Citation Analysis]
365 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 64-85. [DOI: 10.1016/b978-1-4377-0881-3.00005-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
366 Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. Aliment Pharmacol Ther 2012;35:92-104. [PMID: 22035045 DOI: 10.1111/j.1365-2036.2011.04897.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
367 Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
368 Crespo G, Martinez SM, Forns X. Assessing the Progression of Chronic HCV to Cirrhosis. Chronic Hepatitis C Virus 2012. [DOI: 10.1007/978-1-4614-1192-5_3] [Reference Citation Analysis]
369 Berenguer J, Fernandez-rodríguez A, Jimenez-sousa MA, Cosín J, Zarate P, Micheloud D, López JC, Miralles P, Catalán P, Resino S. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients. Cytokine 2012;57:25-9. [DOI: 10.1016/j.cyto.2011.10.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
370 El-shabrawi M, Hassanin F. Noninvasive Diagnosis of Liver Fibrosis. Textbook of Clinical Pediatrics 2012. [DOI: 10.1007/978-3-642-02202-9_211] [Reference Citation Analysis]
371 Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, Bronowicki JP, Gelineau MC, Tran A, Trocme C, De Ledinghen V, Lasnier E, Poujol-Robert A, Ziegler F, Bourliere M, Voitot H, Larrey D, Rosenthal-Allieri MA, Fouchard Hubert I, Bailly F, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012;56:55-62. [PMID: 21781944 DOI: 10.1016/j.jhep.2011.05.024] [Cited by in Crossref: 152] [Cited by in F6Publishing: 159] [Article Influence: 13.8] [Reference Citation Analysis]
372 Wu S, Ni Y, Liu L, Li H, Lu L, Wang J. Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B. Hepatol Int 2012;6:360-8. [DOI: 10.1007/s12072-011-9328-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
373 Tor J, Muga R. [Evaluation of liver fibrosis by non-invasive methods]. Med Clin (Barc) 2011;137:642-4. [PMID: 21752404 DOI: 10.1016/j.medcli.2011.05.002] [Reference Citation Analysis]
374 Arain SA, Jamal Q, Omair A. "Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C. World J Gastroenterol 2011; 17(41): 4607-4613 [PMID: 22147967 DOI: 10.3748/wjg.v17.i41.4607] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
375 Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 2011;43:887-92. [PMID: 21783442 DOI: 10.1016/j.dld.2011.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
376 Ghany MG, Kim HY, Stoddard A, Wright EC, Seeff LB, Lok AS; HALT-C Trial Group. Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial. Hepatology 2011;54:1527-37. [PMID: 22045670 DOI: 10.1002/hep.24550] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
377 Sebastiani G, Castera L, Halfon P, Pol S, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011;34:1202-16. [PMID: 21981787 DOI: 10.1111/j.1365-2036.2011.04861.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 80] [Article Influence: 8.0] [Reference Citation Analysis]
378 Attallah AM, Abdallah SO, El Sayed AS, Omran MM, El-Bendary M, Farid K, Kadry M. Non-invasive predictive score of fibrosis stages in chronic hepatitis C patients based on epithelial membrane antigen in the blood in combination with routine laboratory markers. Hepatol Res 2011;41:1075-84. [PMID: 22035384 DOI: 10.1111/j.1872-034X.2011.00862.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
379 Kotoh K, Fukushima M, Horikawa Y, Yamashita S, Kohjima M, Nakamuta M, Enjoji M. Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis. Exp Ther Med 2012;3:72-5. [PMID: 22969847 DOI: 10.3892/etm.2011.370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
380 Shah AG, Smith PG, Sterling RK. Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT. Dig Dis Sci 2011;56:3038-44. [PMID: 21526398 DOI: 10.1007/s10620-011-1710-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
381 Morikawa H, Kawada N. Non-invasive diagnosis of liver fibrosis. Clin J Gastroenterol 2011;4:283-91. [DOI: 10.1007/s12328-011-0248-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
382 Scaglia E, Sockalingum GD, Schmitt J, Gobinet C, Schneider N, Manfait M, Thiéfin G. Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis C using serum Fourier transform infrared spectroscopy. Anal Bioanal Chem 2011;401:2919-25. [DOI: 10.1007/s00216-011-5402-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
383 Weich V, Herrmann E, Chung TL, Sarrazin C, Hinrichsen H, Buggisch P, Gerlach T, Klinker H, Spengler U, Bergk A. The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection. J Gastroenterol. 2011;46:1427-1436. [PMID: 21912897 DOI: 10.1007/s00535-011-0458-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
384 Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S, Yüksel I, Üsküdar O, Köklü S. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011;25:162-5. [PMID: 21567462 DOI: 10.1002/jcla.20450] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
385 Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, Lei XZ, Liu C, Tang H. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci 2011;56:2742-9. [PMID: 21399926 DOI: 10.1007/s10620-011-1659-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
386 Schmeltzer PA, Talwalkar JA. Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am 2011;40:507-21. [PMID: 21893271 DOI: 10.1016/j.gtc.2011.06.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
387 Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr 2012;171:353-60. [PMID: 21861093 DOI: 10.1007/s00431-011-1558-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
388 Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012;171:353-360. [PMID: 21861093 DOI: 10.1007/s00431-011-1558-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 8.2] [Reference Citation Analysis]
389 Valva P, Casciato P, Diaz Carrasco JM, Gadano A, Galdame O, Galoppo MC, Mullen E, De Matteo E, Preciado MV. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection. PLoS One. 2011;6:e23218. [PMID: 21858035 DOI: 10.1371/journal.pone.0023218] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
390 Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, Fung J, Wong DK, Yuen MF. A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One. 2011;6:e23077. [PMID: 21853071 DOI: 10.1371/journal.pone.0023077] [Cited by in Crossref: 51] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
391 Resino S, Asensio C, Bellón JM, Carmona R, Miralles P, López JC, Cosín J, Álvarez E, Berenguer J. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV/HCV-coinfected patients: a validation study. J Infect. 2011;63:402-405. [PMID: 21839774 DOI: 10.1016/j.jinf.2011.07.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
392 Carrión JA, Navasa M, Buti M, Torras X, Xiol X, Vergara M, Planas R, Solà R, Forns X. Elastografía hepática. Documento de posicionamiento de la Societat Catalana de Digestologia. Gastroenterología y Hepatología 2011;34:504-10. [DOI: 10.1016/j.gastrohep.2011.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
393 Bavu E, Gennisson JL, Couade M, Bercoff J, Mallet V, Fink M, Badel A, Vallet-Pichard A, Nalpas B, Tanter M, Pol S. Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients. Ultrasound Med Biol. 2011;37:1361-1373. [PMID: 21775051 DOI: 10.1016/j.ultrasmedbio.2011.05.016] [Cited by in Crossref: 321] [Cited by in F6Publishing: 328] [Article Influence: 26.8] [Reference Citation Analysis]
394 Rowell J, Thompson AJ, Guyton JR, Lao XQ, McHutchison JG, McCarthy JJ, Patel K. Serum apolipoprotein C-III is independently associated with chronic hepatitis C infection and advanced fibrosis. Hepatol Int. 2012;6:475-481. [PMID: 21735316 DOI: 10.1007/s12072-011-9291-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
395 Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med. 2011;3:69-80. [PMID: 24367223 DOI: 10.2147/hmer.s9051] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
396 Ismail MH, Pinzani M. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med. 2011;3:69-80. [PMID: 24367223 DOI: 10.2147/hmer.s905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
397 Miki D, Ochi H, Hayes CN, Abe H, Yoshima T, Aikata H, Ikeda K, Kumada H, Toyota J, Morizono T. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers. Nat Genet. 2011;43:797-800. [PMID: 21725309 DOI: 10.1038/ng.876] [Cited by in Crossref: 131] [Cited by in F6Publishing: 136] [Article Influence: 10.9] [Reference Citation Analysis]
398 Patel K, Thompson AJ, Chuang WL, Lee CM, Peng CY, Shanmuganathan G, Thongsawat S, Tanwandee T, Mahachai V, Pramoolsinsap C, Cho M, Han KH, Shah SR, Foster GR, Clark PJ, Pulkstenis E, Subramanian GM, McHutchison JG. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients. J Gastroenterol Hepatol 2011;26:1182-8. [PMID: 21410752 DOI: 10.1111/j.1440-1746.2011.06722.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
399 Lee HS, Kim JK, Cheong JY, Han EJ, An SY, Song JH, Jung YJ, Jeon SC, Jung MW, Jang EJ. Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis. Korean J Hepatol. 2010;16:369-375. [PMID: 21415580 DOI: 10.3350/kjhep.2010.16.4.369] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
400 Pár G, Vincze Á, Berki T, Miseta A, Kereskai L, Pajor L, Oszter A, Jakab F, Szereday Z, Nagy Á, Hunyady B, Pár A. Serum fibrosis markers (Procollagen-III-peptide, hyaluronic acid, transforming growth factor β-1), aspartate-aminotransferase to platelet ratio index (APRI), and transient elastography (FibroScan) in patients with chronic HCV infection. Clinical and Experimental Medical Journal 2011;5:101-118. [DOI: 10.1556/cemed.5.2011.2.5] [Reference Citation Analysis]
401 Casanova-esteban P, Guiral N, Andrés E, Gonzalvo C, Mateo-gallego R, Giraldo P, Paramo JA, Civeira F. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Metabolism 2011;60:830-4. [DOI: 10.1016/j.metabol.2010.07.035] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
402 Lee HJ, Seo YS, Kim DJ, Kang HS, An H, Kim JH, Cheong JY, Yim HJ, Yeon JE, Lee HS, Byun KS, Cho SW, Kim DJ, Um SH, Kim CD, Ryu HS. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B. J Gastroenterol Hepatol 2011;26:987-95. [PMID: 21198828 DOI: 10.1111/j.1440-1746.2010.06609.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
403 Kim SU, Han KH, Ahn SH. Non-invasive assessment of liver fibrosis: the gap between ideal and real. J Gastroenterol Hepatol 2011;26:937-9. [PMID: 21564284 DOI: 10.1111/j.1440-1746.2011.06741.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
404 Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, Couzigou P, de Ledinghen V. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970-9, 1979.e1-3. [PMID: 21376047 DOI: 10.1053/j.gastro.2011.02.058] [Cited by in Crossref: 285] [Cited by in F6Publishing: 303] [Article Influence: 23.8] [Reference Citation Analysis]
405 Adams LA. Biomarkers of liver fibrosis. J Gastroenterol Hepatol 2011;26:802-9. [PMID: 21198831 DOI: 10.1111/j.1440-1746.2010.06612.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]
406 J.s. Cross T, Jothimani D, Heneghan MA, Harrison PM. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence: Non-invasive assessment of HCV post OLT. Clinical Transplantation 2011;25:345-51. [DOI: 10.1111/j.1399-0012.2011.01396.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
407 Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, Asad S, Shahid I, Sumrin A, Khaliq S, Jahan S, Pervaiz A, Hassan S. A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol 2011;11:44. [PMID: 21507271 DOI: 10.1186/1471-230X-11-44] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
408 Chongsrisawat V, Vejapipat P, Siripon N, Poovorawan Y. Transient elastography for predicting esophageal/gastric varices in children with biliary atresia. BMC Gastroenterol. 2011;11:41. [PMID: 21501480 DOI: 10.1186/1471-230x-11-41] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
409 Baek JS, Bae EJ, Kim GB, Kim W, Lee JR, Kim YJ, Park E, Lee W, Noh CI. Pulmonary Artery Size and Late Functional Outcome After Fontan Operation. The Annals of Thoracic Surgery 2011;91:1240-6. [DOI: 10.1016/j.athoracsur.2010.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
410 Castera L. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 2011;25:291-303. [PMID: 21497746 DOI: 10.1016/j.bpg.2011.02.003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 8.3] [Reference Citation Analysis]
411 Collazos J, Cartón JA, Asensi V. Immunological status does not influence hepatitis c virus or liver fibrosis in HIV-hepatitis C virus-coinfected patients. AIDS Res Hum Retroviruses 2011;27:383-9. [PMID: 20977357 DOI: 10.1089/aid.2010.0168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
412 Moessner BK, Andersen ES, Weis N, Laursen AL, Ingerslev J, Lethagen S, Pedersen C, Christensen PB. Previously unrecognized advanced liver disease unveiled by transient elastography in patients with Haemophilia and chronic hepatitis C. Haemophilia 2011;17:938-43. [PMID: 21435119 DOI: 10.1111/j.1365-2516.2011.02520.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
413 Koizumi Y, Hirooka M, Kisaka Y, Konishi I, Abe M, Murakami H, Matsuura B, Hiasa Y, Onji M. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography--establishment of the method for measurement. Radiology 2011;258:610-7. [PMID: 21273523 DOI: 10.1148/radiol.10100319] [Cited by in Crossref: 107] [Cited by in F6Publishing: 116] [Article Influence: 8.9] [Reference Citation Analysis]
414 Abdeen S, Olusi SO, George S. Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis. Hepat Med 2011;3:13-8. [PMID: 24367216 DOI: 10.2147/HMER.S17039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
415 Singal AG, Thomassen LV, Gretch DR, Shuhart MC. Use of the AST to platelet ratio index in HCV/HIV co-infected patients. Aliment Pharmacol Ther 2011;33:566-77. [PMID: 21205257 DOI: 10.1111/j.1365-2036.2010.04560.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
416 Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virol J. 2011;8:53. [PMID: 21299910 DOI: 10.1186/1743-422x-8-53] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
417 Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB, Park YN, Cho SW. Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. Dig Dis Sci 2011;56:555-63. [PMID: 20585981 DOI: 10.1007/s10620-010-1305-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
418 Toshima T, Shirabe K, Takeishi K, Motomura T, Mano Y, Uchiyama H, Yoshizumi T, Soejima Y, Taketomi A, Maehara Y. New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver. J Gastroenterol. 2011;46:705-711. [PMID: 21264479 DOI: 10.1007/s00535-010-0365-7] [Cited by in Crossref: 92] [Cited by in F6Publishing: 105] [Article Influence: 7.7] [Reference Citation Analysis]
419 Castera L. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int. 2011;5:625-634. [PMID: 21484142 DOI: 10.1007/s12072-010-9240-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
420 Andersen ES, Ruhwald M, Moessner B, Christensen PB, Andersen O, Eugen-Olsen J, Weis N. Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1. Eur J Clin Microbiol Infect Dis. 2011;30:761-766. [PMID: 21229279 DOI: 10.1007/s10096-010-1149-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
421 Martinez SM, Fernández-Varo G, González P, Sampson E, Bruguera M, Navasa M, Jiménez W, Sánchez-Tapias JM, Forns X. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C. Aliment Pharmacol Ther 2011;33:138-48. [PMID: 21083589 DOI: 10.1111/j.1365-2036.2010.04500.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
422 Khalili H, Dayyeh BA, Friedman LS. Assessment of Liver Function in Clinical Practice. Chronic Liver Failure 2011. [DOI: 10.1007/978-1-60761-866-9_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
423 Pincus MR, Tierno PM, Fenelus M, Bowne WB, Bluth MH. Evaluation of Liver Function. Henry's Clinical Diagnosis and Management by Laboratory Methods 2011. [DOI: 10.1016/b978-1-4377-0974-2.00021-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
424 Parkes J, Guha IN, Roderick P, Harris S, Cross R, Manos MM, Irving W, Zaitoun A, Wheatley M, Ryder S, Rosenberg W. Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C. J Viral Hepat 2011;18:23-31. [PMID: 20196799 DOI: 10.1111/j.1365-2893.2009.01263.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 116] [Article Influence: 10.0] [Reference Citation Analysis]
425 Martínez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011;53:325-35. [PMID: 21254180 DOI: 10.1002/hep.24013] [Cited by in Crossref: 303] [Cited by in F6Publishing: 282] [Article Influence: 25.3] [Reference Citation Analysis]
426 Cholongitas E, Tsochatzis E, Goulis J, Burroughs AK. Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review. Transpl Int. 2010;23:861-870. [PMID: 20704691 DOI: 10.1111/j.1432-2277.2010.01142.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
427 Lee MH, Cheong JY, Um SH, Seo YS, Kim DJ, Hwang SG, Yang JM, Han KH, Cho SW. Comparison of surrogate serum markers and transient elastography (Fibroscan) for assessing cirrhosis in patients with chronic viral hepatitis. Dig Dis Sci 2010;55:3552-60. [PMID: 20428950 DOI: 10.1007/s10620-010-1219-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
428 Li N, Ding H, Fan P, Lin X, Xu C, Wang W, Xu Z, Wang J. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Ultrasound Med Biol. 2010;36:1066-1075. [PMID: 20620694 DOI: 10.1016/j.ultrasmedbio.2010.04.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
429 Sebastiani G, Gkouvatsos K, Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med. 2011;49:13-32. [PMID: 20961196 DOI: 10.1515/cclm.2011.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
430 Ichino N, Osakabe K, Nishikawa T, Sugiyama H, Kato M, Kitahara S, Hashimoto S, Kawabe N, Harata M, Nitta Y, Murao M, Nakano T, Arima Y, Shimazaki H, Suzuki K, Yoshioka K. A new index for non-invasive assessment of liver fibrosis. World J Gastroenterol 2010; 16(38): 4809-4816 [PMID: 20939109 DOI: 10.3748/wjg.v16.i38.4809] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
431 Gana JC, Turner D, Yap J, Adams-webber T, Rashkovan N, Ling SC. Non-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2010. [DOI: 10.1002/14651858.cd008764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
432 Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M, Noventa F, Angeli P, Saggioro A, Alberti A. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. J Hepatol 2010;53:630-8. [PMID: 20615567 DOI: 10.1016/j.jhep.2010.04.019] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 7.0] [Reference Citation Analysis]
433 Papastamataki M, Delaporta P, Premetis E, Kattamis A, Ladis V, Papassotiriou I. Evaluation of liver fibrosis in patients with thalassemia: The important role of hyaluronic acid. Blood Cells, Molecules, and Diseases 2010;45:215-8. [DOI: 10.1016/j.bcmd.2010.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
434 Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL; HALT-C Trial Group. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 2010;59:1401-9. [PMID: 20675691 DOI: 10.1136/gut.2010.207423] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
435 Thabut D, Simon‐rudler M. Non‐Histological Assessment of Liver Fibrosis. Evidence‐Based Gastroenterology and Hepatology 2010. [DOI: 10.1002/9781444314403.ch35] [Reference Citation Analysis]
436 Méndez-Navarro J, Chirino RA, Corey KE, Gorospe EC, Zheng H, Morán S, Juarez JA, Chung RT, Dehesa-Violante M. A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients. Dig Dis Sci 2010;55:2629-35. [PMID: 19960257 DOI: 10.1007/s10620-009-1062-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
437 Kim SU, Han KH, Ahn SH. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. J Gastroenterol Hepatol 2010;25:1472-3. [PMID: 20796140 DOI: 10.1111/j.1440-1746.2010.06432.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
438 Zhou K, Gao CF, Zhao YP, Liu HL, Zheng RD, Xian JC, Xu HT, Mao YM, Zeng MD, Lu LG. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010;25:1569-77. [PMID: 20796157 DOI: 10.1111/j.1440-1746.2010.06383.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 5.8] [Reference Citation Analysis]
439 Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Kim DY. External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients. Dig Dis Sci 2010;55:2636-43. [PMID: 19960253 DOI: 10.1007/s10620-009-1070-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
440 Matas M, Picornell A, Cifuentes C, Payeras A, Bassa A, Homar F, López-Labrador FX, Moya A, Ramon MM, Castro JA. Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patients. Infect Genet Evol 2010;10:1252-61. [PMID: 20732459 DOI: 10.1016/j.meegid.2010.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
441 Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? BMC Infect Dis. 2010;10:244. [PMID: 20723207 DOI: 10.1186/1471-2334-10-244] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
442 Morikawa H, Fukuda K, Kobayashi S, Fujii H, Iwai S, Enomoto M, Tamori A, Sakaguchi H, Kawada N. Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C. J Gastroenterol. 2011;46:350-358. [PMID: 20697747 DOI: 10.1007/s00535-010-0301-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 75] [Article Influence: 4.9] [Reference Citation Analysis]
443 Berenguer J. [Hepatitis C virus infection in HIV coinfected patients]. Rev Clin Esp 2010;210:338-41. [PMID: 20609839 DOI: 10.1016/j.rce.2010.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
444 Morais CNLD, Carvalho BDM, Melo WGD, Melo FLD, Lopes EPDA, Domingues ALC, Jucá N, Martins JRM, Diniz GTN, Montenegro SML. Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients. Mem Inst Oswaldo Cruz 2010;105:460-6. [DOI: 10.1590/s0074-02762010000400018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
445 Park SH, Kim DJ, Cheong JY, Cho SW, Hwang SG, Lee YJ, Cho M, Yang JM, Kim YB. Noninvasive markers to diagnose cirrhosis in patients with HBeAg positive chronic hepatitis: Do new biomarkers improve the accuracy? Clinical Biochemistry 2010;43:877-81. [DOI: 10.1016/j.clinbiochem.2010.04.063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
446 Sanai FM, Keeffe EB. Liver biopsy for histological assessment: The case against. Saudi J Gastroenterol. 2010;16:124-132. [PMID: 20339187 DOI: 10.4103/1319-3767.61244] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
447 González Guilabert MI, Hinojosa Mena-bernal C, del Pozo González J, del Pozo Pérez MA. Estudio retrospectivo de la capacidad de evaluación de fibrosis hepática del FibroScan®, APRI, FIB-4 y FORNS con referencia a la biopsia hepática de pacientes con hepatitis crónica C, mono y coinfectados con VIH. Gastroenterología y Hepatología 2010;33:425-32. [DOI: 10.1016/j.gastrohep.2010.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
448 Hessien MH, El-Sharkawi IM, El-Barbary AA, El-Beltagy DM, Snyder N. Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and Schistosomal infection in mice. BMC Gastroenterol 2010;10:53. [PMID: 20515488 DOI: 10.1186/1471-230X-10-53] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
449 Ibáñez JG, Pérez M, Lamas JL, Ocampo A, Vázquez CM, Ribera A. [Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV]. Rev Clin Esp 2010;210:317-22. [PMID: 20466359 DOI: 10.1016/j.rce.2010.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
450 Wong GL, Wong VW, Choi PC, Chan AW, Chan HL. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2010;31:1095-103. [PMID: 20180785 DOI: 10.1111/j.1365-2036.2010.04276.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 7.2] [Reference Citation Analysis]
451 Jarcuska P, Janicko M, Veselíny E, Jarcuska P, Skladaný L. Circulating markers of liver fibrosis progression. Clin Chim Acta. 2010;411:1009-1017. [PMID: 20399764 DOI: 10.1016/j.cca.2010.04.009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
452 Bailly F, Ahmed SN, Pradat P, Trepo C. Management of nonresponsive hepatitis C. Expert Rev Anti Infect Ther 2010;8:379-95. [PMID: 20377334 DOI: 10.1586/eri.10.17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
453 Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Han KH. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010;30:546-53. [PMID: 20074094 DOI: 10.1111/j.1478-3231.2009.02192.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 130] [Article Influence: 13.3] [Reference Citation Analysis]
454 Pinzani M. Non-invasive systems for staging compensated cirrhosis. Arab Journal of Gastroenterology 2010;10:S32-S34. [DOI: 10.1016/j.ajg.2009.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
455 Sánchez-Conde M, Montes-Ramírez ML, Miralles P, Alvarez JM, Bellón JM, Ramírez M, Arribas JR, Gutiérrez I, López JC, Cosín J, Alvarez E, González J, Berenguer J. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010;17:280-6. [PMID: 19732322 DOI: 10.1111/j.1365-2893.2009.01180.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 6.3] [Reference Citation Analysis]
456 Takahashi H, Ono N, Eguchi Y, Eguchi T, Kitajima Y, Kawaguchi Y, Nakashita S, Ozaki I, Mizuta T, Toda S, Kudo S, Miyoshi A, Miyazaki K, Fujimoto K. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int 2010;30:538-45. [PMID: 19874490 DOI: 10.1111/j.1478-3231.2009.02130.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 153] [Article Influence: 12.5] [Reference Citation Analysis]
457 Cowan ML, Rahman TM, Krishna S. Proteomic approaches in the search for biomarkers of liver fibrosis. Trends Mol Med. 2010;16:171-183. [PMID: 20304704 DOI: 10.1016/j.molmed.2010.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
458 Milner KL, van der Poorten D, Trenell M, Jenkins AB, Xu A, Smythe G, Dore GJ, Zekry A, Weltman M, Fragomeli V, George J, Chisholm DJ. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. Gastroenterology 2010;138:932-41.e1-3. [PMID: 19962985 DOI: 10.1053/j.gastro.2009.11.050] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 7.7] [Reference Citation Analysis]
459 Hackl NJ, Bersch C, Feick P, Antoni C, Franke A, Singer MV, Nakchbandi IA. Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C. Scand J Gastroenterol 2010;45:349-56. [PMID: 20017652 DOI: 10.3109/00365520903490606] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
460 Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C. Altered serum N-glycomics in chronic hepatitis B patients. Liver Int 2010;30:259-67. [PMID: 19951379 DOI: 10.1111/j.1478-3231.2009.02170.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
461 De Bruyne RM, Fitzpatrick E, Dhawan A. Fatty liver disease in children: eat now pay later. Hepatol Int. 2010;4:375-385. [PMID: 20305757 DOI: 10.1007/s12072-009-9160-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
462 Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study. World J Gastroenterol 2010; 16(4): 501-507 [PMID: 20101779 DOI: 10.3748/wjg.v16.i4.501] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
463 Maor Y, Halfon P, Bashari D, Pénaranda G, Morali G, Klar R, Bar-meir S, Martinowitz U, Oren R. Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C. Haemophilia 2010;16:148-54. [DOI: 10.1111/j.1365-2516.2009.02092.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
464 Ladero JM, Delkader J, Ortega L, Fernández C, Devesa MJ, López-Alonso G, Mayol J, Cuenca F, Suárez A, Taxonera C, Díaz-Rubio M. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods. Scand J Gastroenterol 2010;45:51-9. [PMID: 20030577 DOI: 10.3109/00365520903305544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
465 Ray SC, Thomas DL. Hepatitis C. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 2157-85. [DOI: 10.1016/b978-0-443-06839-3.00154-5] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
466 Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010;25:94-100. [PMID: 19793171 DOI: 10.1111/j.1440-1746.2009.05953.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
467 Dancygier H, Schirmacher P. Fibrogenic Reaction. Clinical Hepatology 2010. [DOI: 10.1007/978-3-540-93842-2_28] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
468 Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS. Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. J Korean Med Sci. 2010;25:67-74. [PMID: 20052350 DOI: 10.3346/jkms.2010.25.1.67] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
469 Ismail MH, Pinzani M. Reversal of liver fibrosis. Saudi J Gastroenterol. 2009;15:72-79. [PMID: 19568569 DOI: 10.4103/1319-3767.45072] [Cited by in Crossref: 70] [Cited by in F6Publishing: 81] [Article Influence: 5.0] [Reference Citation Analysis]
470 Stasi C, Arena U, Vizzutti F, Zignego AL, Monti M, Laffi G, Corti G, Pinzani M. Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool? Dig Liver Dis 2009;41:863-6. [PMID: 19482565 DOI: 10.1016/j.dld.2009.04.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
471 Konkle BA, Kessler C, Aledort L, Andersen J, Fogarty P, Kouides P, Quon D, Ragni M, Zakarija A, Ewenstein B. Emerging clinical concerns in the ageing haemophilia patient. Haemophilia 2009;15:1197-209. [DOI: 10.1111/j.1365-2516.2009.02066.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
472 Calès P, Boursier J, Oberti F, Hubert I, Gallois Y, Rousselet MC, Dib N, Moal V, Macchi L, Chevailler A. FibroMeters: a family of blood tests for liver fibrosis. Gastroenterol Clin Biol. 2008;32:40-51. [PMID: 18973845 DOI: 10.1016/s0399-8320(08)73992-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
473 Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009;30:557-76. [PMID: 19519733 DOI: 10.1111/j.1365-2036.2009.04062.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
474 Pissaia A Jr, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology. Transplant Proc. 2009;41:679-681. [PMID: 19328955 DOI: 10.1016/j.transproceed.2008.12.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
475 Blavy P, Gondret F, Guillou H, Lagarrigue S, Martin PG, van Milgen J, Radulescu O, Siegel A. A minimal model for hepatic fatty acid balance during fasting: application to PPAR alpha-deficient mice. J Theor Biol 2009;261:266-78. [PMID: 19635486 DOI: 10.1016/j.jtbi.2009.07.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
476 Lok AS. Hepatitis B: liver fibrosis and hepatocellular carcinoma. Gastroenterol Clin Biol. 2009;33:911-915. [PMID: 19577871 DOI: 10.1016/j.gcb.2009.06.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
477 Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King's Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009;21:730-8. [PMID: 19430302 DOI: 10.1097/MEG.0b013e32830dfcb3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 83] [Article Influence: 6.5] [Reference Citation Analysis]
478 Nitta Y, Kawabe N, Hashimoto S, Harata M, Komura N, Kobayashi K, Arima Y, Shimazaki H, Nakano T, Murao M, Ichino N, Osakabe K, Aoki H, Hosoe Y, Sugiyama H, Nishikawa T, Yoshioka K. Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 2009;39:675-84. [PMID: 19261000 DOI: 10.1111/j.1872-034X.2009.00500.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
479 Fuster D, Torrens M, Tor J, Muga R. Paciente con abuso de alcohol, infección por el VIH y hepatitis crónica C. Trastornos Adictivos 2009;11:173-179. [DOI: 10.1016/s1575-0973(09)72409-2] [Reference Citation Analysis]
480 Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. J Viral Hepat 2009;16:513-8. [PMID: 19200132 DOI: 10.1111/j.1365-2893.2009.01103.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
481 Bottero J, Lacombe K, Guéchot J, Serfaty L, Miailhes P, Bonnard P, Wendum D, Molina JM, Lascoux-Combe C, Girard PM. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol 2009;50:1074-83. [PMID: 19398234 DOI: 10.1016/j.jhep.2009.01.022] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
482 Cheung KJ, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. The HCV serum proteome: a search for fibrosis protein markers. J Viral Hepat 2009;16:418-29. [PMID: 19226329 DOI: 10.1111/j.1365-2893.2009.01083.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 4.4] [Reference Citation Analysis]
483 Carrión JA. Utilidad del Fibroscan® para evaluar la fibrosis hepática. Gastroenterología y Hepatología 2009;32:415-23. [DOI: 10.1016/j.gastrohep.2009.01.178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
484 Denzer UW, Lüth S. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis. Best Pract Res Clin Gastroenterol 2009;23:453-60. [PMID: 19505671 DOI: 10.1016/j.bpg.2009.03.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
485 Becker L, Salameh W, Sferruzza A, Zhang K, ng Chen R, Malik R, Reitz R, Nasser I, Afdhal NH. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol 2009;7:696-701. [PMID: 19514117 DOI: 10.1016/j.cgh.2009.01.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
486 Portilla J, López-Burgos A, Saiz-De-La-Hoya-Zamácola P, Sánchez-Payá J, Bedía-Collantes M, Faraco-Atienzar I, Lissen E. [Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C]. Gastroenterol Hepatol 2009;32:387-94. [PMID: 19477553 DOI: 10.1016/j.gastrohep.2009.01.176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
487 Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009; 15(18): 2190-2203 [PMID: 19437558 DOI: 10.3748/wjg.15.2190] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
488 Castera L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J Viral Hepat 2009;16:300-14. [PMID: 19254351 DOI: 10.1111/j.1365-2893.2009.01087.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 8.5] [Reference Citation Analysis]
489 Feld JJ, Wong DK, Heathcote EJ. Endpoints of therapy in chronic hepatitis B. Hepatology 2009;49:S96-S102. [PMID: 19399800 DOI: 10.1002/hep.22977] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
490 Shire NJ, Rao MB, Succop P, Buncher CR, Andersen JA, Butt AA, Chung RT, Sherman KE; AIDS Clinical Trials Group 5178 Study Group. Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clin Gastroenterol Hepatol 2009;7:471-80, 480.e1-2. [PMID: 19268724 DOI: 10.1016/j.cgh.2008.12.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
491 Moreno S, García-Samaniego J, Moreno A, Ortega E, Pineda JA, del Romero J, Tural C, von Wichmann MA, Berenguer J, Castro A, Espacio R. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection. J Viral Hepat 2009;16:249-58. [PMID: 19215579 DOI: 10.1111/j.1365-2893.2009.01088.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
492 Nelson DR, Davis GL, Jacobson I, Everson GT, Fried MW, Harrison SA, Hassanein T, Jensen DM, Lindsay KL, Terrault N, Zein N. Hepatitis C virus: a critical appraisal of approaches to therapy. Clin Gastroenterol Hepatol 2009;7:397-414; quiz 366. [PMID: 19114127 DOI: 10.1016/j.cgh.2008.11.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
493 Vergniol J, de Ledinghen V. Diagnostic non invasif de la fibrose hépatique : modalités pratiques d’utilisation des marqueurs sanguins et du FibroScan. Gastroentérologie Clinique et Biologique 2009;33:334-44. [DOI: 10.1016/j.gcb.2009.02.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
494 Castera L. Assessing liver fibrosis. Expert Rev Gastroenterol Hepatol. 2008;2:541-552. [PMID: 19072402 DOI: 10.1586/17474124.2.4.541] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
495 Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbenson M, Pulkstenis E, Subramanian GM, McHutchison JG. An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C. J Viral Hepat 2009;16:178-86. [PMID: 19175870 DOI: 10.1111/j.1365-2893.2008.01062.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
496 Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus. Clin Gastroenterol Hepatol 2009;7:339-45. [PMID: 19171202 DOI: 10.1016/j.cgh.2008.11.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
497 Corradi F, Piscaglia F, Flori S, D'Errico-Grigioni A, Vasuri F, Tamé MR, Andreone P, Boni P, Gianstefani A, Bolondi L; Bologna Liver Transplantation Group. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. Dig Liver Dis 2009;41:217-25. [PMID: 18672413 DOI: 10.1016/j.dld.2008.06.009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
498 Moodie EE, Pant Pai N, Klein MB. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. PLoS One. 2009;4:e4517. [PMID: 19223976 DOI: 10.1371/journal.pone.0004517] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
499 Carpentier A, Conti F, Carrière M, Aoudjehane L, Miroux C, Moralès O, Calmus Y, Groux H, Auriault C, Pancré V, Delhem N, Podevin P. Analysis of gene transcription in sera during chronic hepatitis C infection. J Med Virol 2009;81:473-80. [PMID: 19152403 DOI: 10.1002/jmv.21398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
500 Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, Giry C, Vallet-Pichard A, Fontaine H, Pol S. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409-15. [PMID: 19035983 DOI: 10.1111/j.1365-2036.2008.03895.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
501 Salles N, Dussarat P, Foucher J, Villars S, de Lédinghen V. Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients. Gastroenterol Clin Biol. 2009;33:126-132. [PMID: 19193508 DOI: 10.1016/j.gcb.2008.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
502 Adams PC, Pankow JS, Barton JC, Acton RT, Leiendecker-foster C, Mclaren GD, Speechley M, Eckfeldt JH. HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein Cholesterol: The Hemochromatosis and Iron Overload Screening Study. Circ Cardiovasc Genet 2009;2:34-7. [DOI: 10.1161/circgenetics.108.813089] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
503 Foucher J, Reiller B, Jullien V, Léal F, di Cesare ES, Merrouche W, Delile JM, de Lédinghen V. FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. J Viral Hepat 2009;16:121-31. [PMID: 19175876 DOI: 10.1111/j.1365-2893.2008.01050.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
504 Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Changes of non-invasive markers and FibroScan values during HCV treatment. J Viral Hepat 2009;16:132-40. [PMID: 19175875 DOI: 10.1111/j.1365-2893.2008.01055.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 6.3] [Reference Citation Analysis]
505 Giannini EG, Savarino V. HCV and fat: something is missing. J Hepatol 2009;50:421-2; author reply 422-3. [PMID: 19070920 DOI: 10.1016/j.jhep.2008.11.001] [Reference Citation Analysis]
506 Zhou K, Lu LG. Assessment of fibrosis in chronic liver diseases. J Dig Dis 2009;10:7-14. [PMID: 19236541 DOI: 10.1111/j.1751-2980.2008.00356.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
507 Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol 2009;50:36-41. [PMID: 19012989 DOI: 10.1016/j.jhep.2008.07.039] [Cited by in Crossref: 199] [Cited by in F6Publishing: 200] [Article Influence: 14.2] [Reference Citation Analysis]
508 Lu S, Wang J, Kee K, Tseng P. Screening with Ultrasonography of Patients at High-Risk for Hepatocellular Carcinoma: Thrombocytopenia as a Valid Surrogate of Cirrhosis. Liver Cancer 2009. [DOI: 10.1007/978-1-4020-9804-8_10] [Reference Citation Analysis]
509 Denzer UW. Assessment of liver fibrosis: gold standard biopsy? Liver under Constant Attack — From Fat to Viruses 2009. [DOI: 10.1007/978-90-481-2759-7_17] [Reference Citation Analysis]
510 Naveau S, Gaudé G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prévot S, Ngo Y, Munteanu M, Balian A, Njiké-Nakseu M, Perlemuter G, Poynard T. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009;49:97-105. [PMID: 19053048 DOI: 10.1002/hep.22576] [Cited by in Crossref: 206] [Cited by in F6Publishing: 186] [Article Influence: 14.7] [Reference Citation Analysis]
511 Kim SG, Kim YS, Jung SW, Kim HK, Jang JY, Moon JH, Kim HS, Lee JS, Lee MS, Shim CS, Kim BS. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease. Korean J Hepatol 2009;15:42. [DOI: 10.3350/kjhep.2009.15.1.42] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
512 Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(46): 7117-7121 [PMID: 19084920 DOI: 10.3748/wjg.14.7117] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
513 Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, Munteanu M, Massard J, Benhamou Y, Ratziu V. Biomarkers of liver fibrosis. Adv Clin Chem. 2008;46:131-160. [PMID: 19004189 DOI: 10.1016/s0065-2423(08)00404-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 3.3] [Reference Citation Analysis]
514 Srygley FD, Patel K. Noninvasive assessment of liver fibrosis in chronic hepatitis C infection. Curr hepatitis rep 2008;7:164-172. [DOI: 10.1007/s11901-008-0032-0] [Reference Citation Analysis]
515 de Lédinghen V, Poynard T, Wartelle C, Rosenthal E. [Non-invasive evaluation of liver fibrosis in hepatitis C]. Gastroenterol Clin Biol 2008;32:S90-5. [PMID: 18675186 DOI: 10.1016/S0399-8320(08)73271-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
516 Lalazar G, Pappo O, Hershcovici T, Hadjaj T, Shubi M, Ohana H, Hemed N, Ilan Y. A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepat 2008;15:716-28. [PMID: 18638013 DOI: 10.1111/j.1365-2893.2008.01007.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
517 Paggi S, Colli A, Fraquelli M, Viganò M, Del Poggio P, Facciotto C, Colombo M, Ronchi G, Conte D. A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation. J Hepatol 2008;49:564-71. [PMID: 18706734 DOI: 10.1016/j.jhep.2008.07.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
518 Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O, Wakui Y, Kido O, Ninomiya M, Kogure T. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol. 2008;43:720-728. [PMID: 18807134 DOI: 10.1007/s00535-008-2225-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 4.0] [Reference Citation Analysis]
519 Thabut D, Simon-rudler M. Biomarkers of liver fibrosis. Liver Cirrhosis: From Pathophysiology to Disease Management. [DOI: 10.1007/978-1-4020-8656-4_14] [Reference Citation Analysis]
520 Pinzani M, Vizzutti F. Clinical evaluation of disease progression in chronic liver disease: towards an integrated system? Liver Cirrhosis: From Pathophysiology to Disease Management. [DOI: 10.1007/978-1-4020-8656-4_15] [Reference Citation Analysis]
521 Forns X. Diagnosis of liver fibrosis in 2008. Gastroentérologie Clinique et Biologique 2008;32:1-3. [DOI: 10.1016/s0399-8320(08)73988-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
522 Wong GL, Wong VW, Choi PC, Chan AW, Chum RH, Chan HK, Lau KK, Chim AM, Yiu KK, Chan FK, Sung JJ, Chan HL. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 2008;6:1027-35. [PMID: 18456573 DOI: 10.1016/j.cgh.2008.02.038] [Cited by in Crossref: 119] [Cited by in F6Publishing: 98] [Article Influence: 7.9] [Reference Citation Analysis]
523 Bourlière M, Pénaranda G, Adhoute X, Oules V, Castellani P. Combining non-invasive methods for assessment of liver fibrosis. Gastroentérologie Clinique et Biologique 2008;32:73-9. [DOI: 10.1016/s0399-8320(08)73996-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
524 Bourliere M, Penaranda G, Ouzan D, Renou C, Botta-Fridlund D, Tran A, Rosenthal E, Wartelle-Bladou C, Delasalle P, Oules V, Portal I, Castellani P, Lecomte L, Rosenthal-Allieri MA, Halfon P. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients. Aliment Pharmacol Ther 2008;28:458-67. [PMID: 18498446 DOI: 10.1111/j.1365-2036.2008.03742.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
525 Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol 2008;103:1973-80. [PMID: 18796094 DOI: 10.1111/j.1572-0241.2008.01954.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
526 Cross T, Antoniades C, Harrison P. Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatol Res 2008;38:762-9. [PMID: 18462378 DOI: 10.1111/j.1872-034X.2008.00364.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
527 Miki D, Aikata H, Uka K, Saneto H, Kawaoka T, Azakami T, Takaki S, Jeong SC, Imamura M, Kawakami Y, Takahashi S, Itamoto T, Asahara T, Arihiro K, Chayama K. Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol. 2008;43:550-557. [PMID: 18648742 DOI: 10.1007/s00535-008-2194-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
528 Leroy V, Halfon P, Bacq Y, Boursier J, Rousselet MC, Bourlière M, de Muret A, Sturm N, Hunault G, Penaranda G. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem. 2008;41:1368-1376. [PMID: 18655779 DOI: 10.1016/j.clinbiochem.2008.06.020] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.4] [Reference Citation Analysis]
529 Török NJ. Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol. 2008;43:315-321. [PMID: 18592147 DOI: 10.1007/s00535-008-2181-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
530 Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, Tan CK, Chow WC. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Pharmacol Ther 2008;28:51-61. [PMID: 18410556 DOI: 10.1111/j.1365-2036.2008.03711.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
531 Adhoute X, Foucher J, Laharie D, Terrebonne E, Vergniol J, Castéra L, Lovato B, Chanteloup E, Merrouche W, Couzigou P. Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterol Clin Biol. 2008;32:180-187. [PMID: 18496894 DOI: 10.1016/j.gcb.2007.12.021] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 4.5] [Reference Citation Analysis]
532 Pankow JS, Boerwinkle E, Adams PC, Guallar E, Leiendecker-Foster C, Rogowski J, Eckfeldt JH. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res 2008;152:3-10. [PMID: 18593631 DOI: 10.1016/j.trsl.2008.05.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
533 Han KH, Yoon KT. New diagnostic method for liver fibrosis and cirrhosis. Intervirology. 2008;51 Suppl 1:11-16. [PMID: 18544943 DOI: 10.1159/000122594] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
534 de Lédinghen V, Barreiro P, Foucher J, Labarga P, Castéra L, Vispo ME, Bernard PH, Martin-Carbonero L, Neau D, García-Gascó P, Merrouche W, Soriano V. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat 2008;15:427-33. [PMID: 18221303 DOI: 10.1111/j.1365-2893.2007.00962.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 4.9] [Reference Citation Analysis]
535 Aita JS, Harrison SA. Liver biopsy versus noninvasive testing in chronic hepatitis C: Where do we stand in 2008? Curr hepatitis rep 2008;7:51-9. [DOI: 10.1007/s11901-008-0008-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
536 Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Leutner M, Pirisi M. Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C. Clin Chem Lab Med 2008;46:253-9. [PMID: 18324909 DOI: 10.1515/CCLM.2008.051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
537 Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371-8. [PMID: 18083083 DOI: 10.1016/j.dld.2007.10.019] [Cited by in Crossref: 300] [Cited by in F6Publishing: 294] [Article Influence: 20.0] [Reference Citation Analysis]
538 Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02. J Hepatol 2008;48:765-73. [PMID: 18314219 DOI: 10.1016/j.jhep.2008.01.025] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
539 Niederau C, Lange S, Frühauf M, Thiel A. Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver Int 2008;28:659-66. [PMID: 18312288 DOI: 10.1111/j.1478-3231.2008.01694.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
540 Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 2008;103:1136-44. [PMID: 18477344 DOI: 10.1111/j.1572-0241.2008.01813.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 9.3] [Reference Citation Analysis]
541 Carrión JA, Navasa M, Forns X. MR Elastography to Assess Liver Fibrosis. Radiology 2008;247:591-2. [DOI: 10.1148/radiol.2472071844] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
542 Cheung KJ, Tilleman K, Deforce D, Colle I, Van Vlierberghe H. Proteomics in liver fibrosis is more than meets the eye. Eur J Gastroenterol Hepatol 2008;20:450-64. [PMID: 18403948 DOI: 10.1097/MEG.0b013e3282f4de92] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
543 Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008;134:1670-81. [PMID: 18471546 DOI: 10.1053/j.gastro.2008.03.001] [Cited by in Crossref: 298] [Cited by in F6Publishing: 320] [Article Influence: 19.9] [Reference Citation Analysis]
544 Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J. 2008;411:1-18. [PMID: 18333835 DOI: 10.1042/bj20071570] [Cited by in Crossref: 227] [Cited by in F6Publishing: 250] [Article Influence: 15.1] [Reference Citation Analysis]
545 Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection. Liver Int 2008;28:486-93. [PMID: 18339075 DOI: 10.1111/j.1478-3231.2008.01675.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
546 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1056/s0140-6736(08)60383-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
547 Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851. [PMID: 18328931 DOI: 10.1016/s0140-6736(08)60383-9] [Cited by in Crossref: 1387] [Cited by in F6Publishing: 1184] [Article Influence: 92.5] [Reference Citation Analysis]
548 Romero-Gómez M, Gómez-González E, Madrazo A, Vera-Valencia M, Rodrigo L, Pérez-Alvarez R, Pérez-López R, Castellano-Megias VM, Nevado-Santos M, Alcón JC, Solá R, Pérez-Moreno JM, Navarro JM, Andrade RJ, Salmerón J, Fernández-López M, Aznar R, Diago M. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology 2008;47:810-6. [PMID: 18098299 DOI: 10.1002/hep.22112] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
549 Myara A, Guechot J, Lasnier E, Imbert-Bismut F, Voitot H, Ferard G. The use of enzyme results for liver fibrosis evaluation neccessitates standardization. Hepatology 2008;47:1100-1. [PMID: 18266251 DOI: 10.1002/hep.22128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
550 Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, Su GL, Ghosh M, Wright EC; HALT-C Trial Group. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008;47:789-98. [PMID: 18175357 DOI: 10.1002/hep.22099] [Cited by in Crossref: 132] [Cited by in F6Publishing: 119] [Article Influence: 8.8] [Reference Citation Analysis]
551 Sebastiani G, Vario A, Guido M, Alberti A. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat 2008;15:212-8. [PMID: 18179453 DOI: 10.1111/j.1365-2893.2007.00932.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
552 Halfon P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Cacoub P. Effect of Antiviral Treatment on Serum Markers of Liver Fibrosis in HIV–Hepatitis C virus-Coinfected Patients: The Fibrovic 2 Study – ANRS HC02. Antiviral Therapy 2009;14:211-9. [DOI: 10.1177/135965350901400205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
553 Pinzani M, Vizzutti F, Arena U, Marra F. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Rev Gastroenterol Hepatol 2008;5:95-106. [DOI: 10.1038/ncpgasthep1025] [Cited by in Crossref: 125] [Cited by in F6Publishing: 141] [Article Influence: 8.3] [Reference Citation Analysis]
554 Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med. 2007;11:1031-1051. [PMID: 17979881 DOI: 10.1111/j.1582-4934.2007.00092.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
555 Berenguer M, Forns X. Cirrosis por el virus de la hepatitis C. Trasplante hepático 2008. [DOI: 10.1016/b978-84-8086-310-0.50030-0] [Reference Citation Analysis]
556 Westin J, Ydreborg M, Islam S, Alsiö A, Dhillon AP, Pawlotsky JM, Zeuzem S, Schalm SW, Ferrari C, Neumann AU, Hellstrand K, Lagging M; DITTO-HCV Study Group. A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection. Scand J Gastroenterol 2008;43:73-80. [PMID: 18938750 DOI: 10.1080/00365520701514461] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
557 Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 2007;9:987-92. [PMID: 18030367 DOI: 10.1593/neo.07781] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 4.4] [Reference Citation Analysis]
558 Yatsuji S, Hashimoto E, Tobari M, Tokushige K, Shiratori K. Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. Hepatol Res 2007;37:1034-43. [PMID: 17610504 DOI: 10.1111/j.1872-034X.2007.00156.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
559 Berenguer J, Bellón JM, Miralles P, Alvarez E, Sánchez-Conde M, Cosín J, López JC, Alvarez F, Catalán P, Resino S. Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data. J Viral Hepat 2007;14:859-69. [PMID: 18070289 DOI: 10.1111/j.1365-2893.2007.00881.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
560 Abdo AA, Al Swat K, Azzam N, Ahmed S, Al Faleh F. Validation of three noninvasive laboratory variables to predict significant fibrosis and cirrhosis in patients with chronic hepatitis C in Saudi Arabia. Ann Saudi Med 2007;27:89-93. [PMID: 17356320 DOI: 10.5144/0256-4947.2007.89] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
561 Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation. J Gastroenterol Hepatol 2007;22:1904-8. [PMID: 17914968 DOI: 10.1111/j.1440-1746.2006.04628.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
562 Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007;102:2589-600. [PMID: 17850410 DOI: 10.1111/j.1572-0241.2007.01466.x] [Cited by in Crossref: 250] [Cited by in F6Publishing: 259] [Article Influence: 15.6] [Reference Citation Analysis]
563 Sherman M. Surveillance for hepatocellular carcinoma and early diagnosis. Clin Liver Dis 2007;11:817-37, viii. [PMID: 17981230 DOI: 10.1016/j.cld.2007.08.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
564 Maor Y, Calès P, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-meir S, Martinowitz U, Halfon P. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients. Haemophilia 2007;13:722-9. [DOI: 10.1111/j.1365-2516.2007.01548.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
565 Lorenzo-Zúñiga V, Bartolí R, Masnou H, Montoliu S, Morillas RM, Planas R. Serum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C. Dig Dis Sci 2007;52:3245-50. [PMID: 17410466 DOI: 10.1007/s10620-006-9437-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
566 Morra R, Munteanu M, Imbert-Bismut F, Messous D, Ratziu V, Poynard T. FibroMAX: towards a new universal biomarker of liver disease? Expert Rev Mol Diagn 2007;7:481-90. [PMID: 17892356 DOI: 10.1586/14737159.7.5.481] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
567 Liu CH, Hsu SJ, Lin JW, Hwang JJ, Liu CJ, Yang PM, Lai MY, Chen PJ, Chen JH, Kao JH, Chen DS. Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. Clin Gastroenterol Hepatol 2007;5:1199-1206.e1. [PMID: 17916547 DOI: 10.1016/j.cgh.2007.07.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
568 Ferraioli G, Gulizia R, Filice C. Real-time elastography in the assessment of liver fibrosis. AJR Am J Roentgenol. 2007;189:W170. [PMID: 17715090 DOI: 10.2214/ajr.07.2318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
569 Gutierrez-Reyes G, Gutierrez-Ruiz MC, Kershenobich D. Liver fibrosis and chronic viral hepatitis. Arch Med Res 2007;38:644-51. [PMID: 17613356 DOI: 10.1016/j.arcmed.2006.10.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
570 Zarski J, Bedossa P, Bronowicki J, Doffoel M, Poynard T. Utilisation des marqueurs non invasifs de fibrose dans la prise en charge de l’hépatite C. Gastroentérologie Clinique et Biologique 2007;31:34-9. [DOI: 10.1016/s0399-8320(07)92561-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
571 García-Samaniego J, Forns X. Hepatitis C virus and human immunodeficiency virus: the un-won battle. Hepatology 2007;46:611-4. [PMID: 17879358 DOI: 10.1002/hep.21818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
572 Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007;46:912-21. [PMID: 17705266 DOI: 10.1002/hep.21835] [Cited by in Crossref: 268] [Cited by in F6Publishing: 226] [Article Influence: 16.8] [Reference Citation Analysis]
573 Lewin M, Poujol-Robert A, Boëlle PY, Wendum D, Lasnier E, Viallon M, Guéchot J, Hoeffel C, Arrivé L, Tubiana JM, Poupon R. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007;46:658-65. [PMID: 17663420 DOI: 10.1002/hep.21747] [Cited by in Crossref: 205] [Cited by in F6Publishing: 206] [Article Influence: 12.8] [Reference Citation Analysis]
574 Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, Cho SW, Han KH, Chon CY, Moon YM, Ahn SH. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int 2007;27:969-76. [PMID: 17696936 DOI: 10.1111/j.1478-3231.2007.01519.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 4.8] [Reference Citation Analysis]
575 Stauber RE, Lackner C. Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. World J Gastroenterol 2007; 13(32): 4287-4294 [PMID: 17708599 DOI: 10.3748/wjg.v13.i32.4287] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
576 Everson GT, Martucci MA, Shiffman ML, Sterling RK, Morgan TR, Hoefs JC; HALT-C trial group. Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt. Aliment Pharmacol Ther 2007;26:401-10. [PMID: 17635375 DOI: 10.1111/j.1365-2036.2007.03389.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
577 Palacios Pérez Á, Salmerón Escobar J. Papel de la biopsia hepática en el diagnóstico y el control de la hepatitis C crónica. Gastroenterología y Hepatología 2007;30:402-7. [DOI: 10.1157/13108806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
578 Schmilovitz-Weiss H, Cohen M, Pappo O, Sulkes J, Braun M, Tur-Kaspa R, Ben-Ari Z. Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection. Clin Transplant. 2007;21:391-397. [PMID: 17488390 DOI: 10.1111/j.1399-0012.2007.00657.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
579 Backus LI, Boothroyd DB, Phillips BR, Mole LA. Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology 2007;46:37-47. [PMID: 17567830 DOI: 10.1002/hep.21662] [Cited by in Crossref: 172] [Cited by in F6Publishing: 144] [Article Influence: 10.8] [Reference Citation Analysis]
580 Goenka N, Subramanian S, Weston P, Vora J. Non-alcoholic fatty liver disease: more than ‘just a bit of fatty liver’. Pract Diab Int 2007;24:305-8. [DOI: 10.1002/pdi.1130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
581 Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-6. [PMID: 17567829 DOI: 10.1002/hep.21669] [Cited by in Crossref: 1256] [Cited by in F6Publishing: 1072] [Article Influence: 78.5] [Reference Citation Analysis]
582 Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, Xie H, Wang J, Han Y, Liu Z. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract. 2008;62:1056-1062. [PMID: 17537188 DOI: 10.1111/j.1742-1241.2007.01368.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 3.1] [Reference Citation Analysis]
583 Burroughs AK, Cholongitas E. Non-invasive tests for liver fibrosis: encouraging or discouraging results? J Hepatol 2007;46:751-5. [PMID: 17383047 DOI: 10.1016/j.jhep.2007.02.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
584 Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007;46:775-82. [PMID: 17321634 DOI: 10.1016/j.jhep.2006.12.013] [Cited by in Crossref: 172] [Cited by in F6Publishing: 172] [Article Influence: 10.8] [Reference Citation Analysis]
585 Boursier J, Dib N, Oberti F, Calès P. Caractéristiques et interprétation des tests sanguins de fibrose hépatique. Gastroentérologie Clinique et Biologique 2007;31:511-23. [DOI: 10.1016/s0399-8320(07)89421-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
586 Chen TM, Huang PT, Tsai MH, Lin LF, Liu CC, Ho KS, Siauw CP, Chao PL, Tung JN. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. J Gastroenterol Hepatol 2007;22:669-75. [PMID: 17444854 DOI: 10.1111/j.1440-1746.2007.04898.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
587 Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360-9. [PMID: 17439526 DOI: 10.1111/j.1365-2893.2006.00811.x] [Cited by in Crossref: 484] [Cited by in F6Publishing: 441] [Article Influence: 30.3] [Reference Citation Analysis]
588 Friedrich-Rust M, Ong MF, Herrmann E, Dries V, Samaras P, Zeuzem S, Sarrazin C. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol. 2007;188:758-764. [PMID: 17312065 DOI: 10.2214/ajr.06.0322] [Cited by in Crossref: 229] [Cited by in F6Publishing: 257] [Article Influence: 14.3] [Reference Citation Analysis]
589 Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl Res. 2007;149:114-125. [PMID: 17320797 DOI: 10.1016/j.trsl.2006.11.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
590 Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Am J Med. 2007;120:280.e9-280.14. [PMID: 17349453 DOI: 10.1016/j.amjmed.2006.06.044] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
591 Saiz de la Hoya-Zamácola P, Marco-Mouriño A, Clemente-Ricote G, Portilla-Sogorb J, Boix-Martínez V, Núñez-Martínez O, Reus-Bañuls S, Teixidó i Pérez N. [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting]. Enferm Infecc Microbiol Clin 2006;24:568-75. [PMID: 17125677 DOI: 10.1157/13093878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
592 Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. Clin J Am Soc Nephrol. 2007;2:563-575. [PMID: 17699464 DOI: 10.2215/cjn.02930806] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 3.6] [Reference Citation Analysis]
593 Halfon P, Bourlière M, Pénaranda G, Cacoub P. Intérêt et limites des méthodes non invasives de prédiction de la fibrose hépatique au cours de l'hépatite C: une alternative à la biopsie hépatique. La Presse Médicale 2007;36:457-66. [DOI: 10.1016/j.lpm.2007.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
594 Sterling RK, Lyons CD, Stravitz RT, Luketic VA, Sanyal AJ, Carr ME, Smith TJ, Hackney MH, Contos MJ, Mills SA, Kuhn JG, Nolte ME, Shiffman ML. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease. Haemophilia 2007;13:164-71. [DOI: 10.1111/j.1365-2516.2006.01322.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
595 Kadam JS, Talal AH. Changing treatment paradigms: hepatitis C virus in HIV-infected patients. AIDS Patient Care STDS 2007;21:154-68. [PMID: 17428183 DOI: 10.1089/apc.2006.0126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
596 Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007;381:107-113. [PMID: 17399697 DOI: 10.1016/j.cca.2007.02.038] [Cited by in Crossref: 136] [Cited by in F6Publishing: 149] [Article Influence: 8.5] [Reference Citation Analysis]
597 Plebani M, Basso D. Non-invasive assessment of chronic liver and gastric diseases. Clin Chim Acta. 2007;381:39-49. [PMID: 17374528 DOI: 10.1016/j.cca.2007.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
598 Nguyen-khac E. Résultats et place du Fibroscan® dans le diagnostic non invasif de la fibrose hépatique. La Revue de Médecine Interne 2007;28:94-102. [DOI: 10.1016/j.revmed.2006.10.329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
599 Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007;45:297-306. [PMID: 17256741 DOI: 10.1002/hep.21520] [Cited by in Crossref: 175] [Cited by in F6Publishing: 158] [Article Influence: 10.9] [Reference Citation Analysis]
600 Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007; 13(4): 525-531 [PMID: 17278217 DOI: 10.3748/wjg.v13.i4.525] [Cited by in CrossRef: 101] [Cited by in F6Publishing: 108] [Article Influence: 6.3] [Reference Citation Analysis]
601 de Franchis R, Dell'Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol 2007;21:3-18. [PMID: 17223493 DOI: 10.1016/j.bpg.2006.07.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
602 Brissot P, Ropert-bouchet M, Troadec M, Lorho R, Guyader D, Loréal O. Exploration biologique hépatique. EMC - Hépatologie 2007;2:1-6. [DOI: 10.1016/s1155-1976(07)46231-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
603 Gressner AM, Arndt T. F. Lexikon der Medizinischen Laboratoriumsdiagnostik 2007. [DOI: 10.1007/978-3-540-49520-8_6] [Reference Citation Analysis]
604 Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis 2007;190:216-23. [DOI: 10.1016/j.atherosclerosis.2006.01.024] [Cited by in Crossref: 131] [Cited by in F6Publishing: 137] [Article Influence: 8.2] [Reference Citation Analysis]
605 Ganne-Carrié N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, Dhumeaux D, Trinchet JC, Beaugrand M. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-7. [PMID: 17133503 DOI: 10.1002/hep.21420] [Cited by in Crossref: 368] [Cited by in F6Publishing: 315] [Article Influence: 21.6] [Reference Citation Analysis]
606 Piscaglia F, Cucchetti A, Benlloch S, Vivarelli M, Berenguer J, Bolondi L, Pinna AD, Berenguer M. Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors. Eur J Gastroenterol Hepatol 2006;18:1255-61. [PMID: 17099373 DOI: 10.1097/01.meg.0000243885.55562.7e] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
607 Nguyen-Khac E, Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan). Eur J Gastroenterol Hepatol 2006;18:1321-5. [PMID: 17099382 DOI: 10.1097/01.meg.0000243884.55562.37] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
608 Albanis E, Friedman SL. Diagnosis of hepatic fibrosis in patients with chronic hepatitis C. Clin Liver Dis 2006;10:821-33. [PMID: 17164119 DOI: 10.1016/j.cld.2006.08.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
609 Saiz de la Hoya-zamácola P, Marco-mouriño A, Clemente-ricote G, Portilla-sogorb J, Boix-martínez V, Núñez-martínez Ó, Reus-bañuls S, Teixidó i Pérez N. Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario. Gastroenterología y Hepatología 2006;29:551-9. [DOI: 10.1157/13094351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
610 Narasimhan G, Sargios TN, Kalakuntla R, Homel P, Clain DJ, Theise ND, Bodenheimer HC Jr, Min AD. Treatment rates in patients with chronic hepatitis C after liver biopsy. J Viral Hepat 2006;13:783-6. [PMID: 17052279 DOI: 10.1111/j.1365-2893.2006.00763.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
611 Guéchot J. [Noninvasive assessment of liver fibrosis in patients with chronic hepatitis virus C]. Presse Med. 2006;35:1317-1326. [PMID: 16969327 DOI: 10.1016/s0755-4982(06)74811-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
612 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
613 Barreiro P, Labarga P, Martín-carbonero L, Amor A, Ruiz-sancho A, Castellares C, González-lahoz J, Soriano V. Sustained Virological Response following HCV Therapy is Associated with Non-Progression of Liver Fibrosis in HCV/HIV-Coinfected Patients. Antiviral Therapy 2006;11:869-878. [DOI: 10.1177/135965350601100706] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
614 Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, Tur-Kaspa R, Ben-Ari Z. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection. J Viral Hepat 2006;13:671-7. [PMID: 16970598 DOI: 10.1111/j.1365-2893.2006.00744.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
615 Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. J Viral Hepat 2006;13:643-51. [PMID: 16970595 DOI: 10.1111/j.1365-2893.2006.00730.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
616 Fontana RJ, Kleiner DE, Bilonick R, Terrault N, Afdhal N, Belle SH, Jeffers LJ, Ramcharran D, Ghany MG, Hoofnagle JH; Virahep-C Study Group. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology 2006;44:925-35. [PMID: 17006909 DOI: 10.1002/hep.21335] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
617 Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006;13:659-70. [PMID: 16970597 DOI: 10.1111/j.1365-2893.2006.00736.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 6.1] [Reference Citation Analysis]
618 Posthouwer D, Fischer K, van Erpecum KJ, Mauser-Bunschoten EP. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders. Transfusion. 2006;46:1360-1366. [PMID: 16934072 DOI: 10.1111/j.1537-2995.2006.00903.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
619 Jiang Z, Yamauchi K, Yoshioka K, Aoki K, Kuroyanagi S, Iwata A, Yang J, Wang K. Support Vector Machine-Based Feature Selection for Classification of Liver Fibrosis Grade in Chronic Hepatitis C. J Med Syst 2006;30:389-94. [DOI: 10.1007/s10916-006-9023-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
620 Sène D, Limal N, Messous D, Ghillani-Dalbin P, Charlotte F, Thiollière JM, Piette JC, Imbert-Bismut F, Halfon P, Poynard T, Cacoub P. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis. Clin Biochem 2006;39:715-21. [PMID: 16765932 DOI: 10.1016/j.clinbiochem.2006.04.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
621 Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, Lebray P, Thibault V, Benhamou Y, Moussalli J. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem. 2006;52:1887-1896. [PMID: 16931569 DOI: 10.1373/clinchem.2006.070961] [Cited by in Crossref: 176] [Cited by in F6Publishing: 191] [Article Influence: 10.4] [Reference Citation Analysis]
622 Testa R, Testa E, Giannini E, Borro P, Milazzo S, Isola L, Ceppa P, Lantieri PB, Risso D. Noninvasive ratio indexes to evaluate fibrosis staging in chronic hepatitis C: role of platelet count/spleen diameter ratio index. J Intern Med. 2006;260:142-150. [PMID: 16882278 DOI: 10.1111/j.1365-2796.2006.01673.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
623 Brady CW, Mchutchison JG, Patel K. Fibrosis markers in hepatitis C. Curr hepatitis rep 2006;5:86-93. [DOI: 10.1007/s11901-006-0010-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
624 Serrano Grau P, Mascaró Galy JM. Metotrexato: actualización en el tratamiento de la psoriasis. Piel 2006;21:358-363. [DOI: 10.1016/s0213-9251(06)72510-2] [Reference Citation Analysis]
625 Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int 2006;26:666-72. [PMID: 16842322 DOI: 10.1111/j.1478-3231.2006.01287.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 107] [Article Influence: 6.2] [Reference Citation Analysis]
626 Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, Soloway R, Petersen J. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 2006;40:535-42. [PMID: 16825937 DOI: 10.1097/00004836-200607000-00013] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 4.9] [Reference Citation Analysis]
627 Pockros PJ. Noninvasive markers of fibrosis in chronic hepatitis patients. J Clin Gastroenterol 2006;40:461-3. [PMID: 16825925 DOI: 10.1097/00004836-200607000-00001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
628 Attallah AM, Toson EA, El-waseef AM, Abo-seif MA, Omran MM, Shiha GE. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Clinica Chimica Acta 2006;369:66-72. [DOI: 10.1016/j.cca.2006.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
629 Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Penaranda G, Bar-meir S, Martinowitz U, Halfon P. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy? Haemophilia 2006;12:372-9. [DOI: 10.1111/j.1365-2516.2006.01290.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
630 Giannini EG, Zaman A, Ceppa P, Mastracci L, Risso D, Testa R. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice. J Clin Gastroenterol 2006;40:521-7. [PMID: 16825935 DOI: 10.1097/00004836-200607000-00011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
631 Thuluvath PJ, Krok KL. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol 2006;101:1497-9. [PMID: 16863552 DOI: 10.1111/j.1572-0241.2005.00304.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
632 Al-Mohri H, Cooper C, Murphy T, Klein MB. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med. 2005;6:375-378. [PMID: 16268817 DOI: 10.1111/j.1468-1293.2005.00330.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 4.2] [Reference Citation Analysis]
633 Ohmoto K, Yoshioka N, Yamamoto S. Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis. J Gastroenterol 2006;41:502-3. [DOI: 10.1007/s00535-006-1778-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
634 Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694 [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682] [Cited by in CrossRef: 180] [Cited by in F6Publishing: 188] [Article Influence: 10.6] [Reference Citation Analysis]
635 Halfon P, Bourlière M, Pénaranda G, Cacoub P. [Serum markers of non-invasive fibrosis in chronic hepatitis C virus infection]. Rev Med Interne 2006;27:751-61. [PMID: 16815598 DOI: 10.1016/j.revmed.2006.03.037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
636 Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M; APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-25. [PMID: 16729309 DOI: 10.1002/hep.21178] [Cited by in Crossref: 2543] [Cited by in F6Publishing: 2155] [Article Influence: 149.6] [Reference Citation Analysis]
637 Huwart L, Salameh N, Van Beers B. L’élastographie du foie, c’est quoi ? Feuillets de Radiologie 2006;46:211-215. [DOI: 10.1016/s0181-9801(06)70517-6] [Reference Citation Analysis]
638 Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, Dhillon AP, Burroughs AK. A Systematic Review of the Quality of Liver Biopsy Specimens. Am J Clin Pathol 2006;125:710-21. [DOI: 10.1309/w3xcnt4hkfbn2g0b] [Cited by in Crossref: 163] [Cited by in F6Publishing: 105] [Article Influence: 9.6] [Reference Citation Analysis]
639 Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouillères O, de Lédinghen V, Dhumeaux D, Marcellin P, Beaugrand M, Poupon R. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006;43:1118-24. [PMID: 16628644 DOI: 10.1002/hep.21151] [Cited by in Crossref: 318] [Cited by in F6Publishing: 267] [Article Influence: 18.7] [Reference Citation Analysis]
640 Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006;55:569-78. [PMID: 16531536 DOI: 10.1136/gut.2005.084475] [Cited by in Crossref: 308] [Cited by in F6Publishing: 278] [Article Influence: 18.1] [Reference Citation Analysis]
641 Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:686-93. [PMID: 16490278 DOI: 10.1016/j.jhep.2006.01.007] [Cited by in Crossref: 197] [Cited by in F6Publishing: 194] [Article Influence: 11.6] [Reference Citation Analysis]
642 Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, Archimandritis AJ. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Eur J Gastroenterol Hepatol 2006;18:389-96. [PMID: 16538110 DOI: 10.1097/00042737-200604000-00012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
643 Lebensztejn DM, Skiba E, Tobolczyk J, Sobaniec-Lotowska ME, Kaczmarski M. Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis. World J Gastroenterol 2005;11:7192-6. [PMID: 16437671 DOI: 10.3748/wjg.v11.i45.7192] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
644 Colli A, Colucci A, Paggi S, Fraquelli M, Massironi S, Andreoletti M, Michela V, Conte D. Accuracy of a predictive model for severe hepatic fibrosis or cirrhosis in chronic hepatitis C. World J Gastroenterol 2005;11:7318-22. [PMID: 16437635 DOI: 10.3748/wjg.v11.i46.7318] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
645 Pinzani M. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut 2006;55:310-2. [PMID: 16474104 DOI: 10.1136/gut.2005.068585] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
646 Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006;44:462-74. [PMID: 16427156 DOI: 10.1016/j.jhep.2005.10.019] [Cited by in Crossref: 173] [Cited by in F6Publishing: 182] [Article Influence: 10.2] [Reference Citation Analysis]
647 Blasco A, Forns X, Carrión JA, García-Pagán JC, Gilabert R, Rimola A, Miquel R, Bruguera M, García-Valdecasas JC, Bosch J, Navasa M. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006;43:492-9. [PMID: 16496308 DOI: 10.1002/hep.21090] [Cited by in Crossref: 238] [Cited by in F6Publishing: 186] [Article Influence: 14.0] [Reference Citation Analysis]
648 Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, Portal I, Allemand I, Bertrand JJ, Rosenthal-Allieri A, Rotily M, Sattonet C, Benderitter T, Saint Paul MC, Bonnot HP, Penaranda G, Degott C, Masseyeff MF, Ouzan D. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 2006;101:547-55. [PMID: 16542291 DOI: 10.1111/j.1572-0241.2006.00411.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 5.9] [Reference Citation Analysis]
649 Macías J, Girón-González JA, González-Serrano M, Merino D, Cano P, Mira JA, Arizcorreta-Yarza A, Ruíz-Morales J, Lomas-Cabeza JM, García-García JA, Corzo JE, Pineda JA. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 2006;55:409-14. [PMID: 16118349 DOI: 10.1136/gut.2005.065904] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
650 Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Pirisi M. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index. Clin Biochem 2006;39:339-43. [PMID: 16487951 DOI: 10.1016/j.clinbiochem.2006.01.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
651 Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006;43:S113-20. [PMID: 16447288 DOI: 10.1002/hep.21046] [Cited by in Crossref: 239] [Cited by in F6Publishing: 221] [Article Influence: 14.1] [Reference Citation Analysis]
652 Alter H. Viral hepatitis. Hepatology 2006;43:S230-4. [PMID: 16447286 DOI: 10.1002/hep.21030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
653 Dufour DR. Assessment of liver fibrosis: Can serum become the sample of choice. Clin Chem. 2005;51:1763-1764. [PMID: 16189374 DOI: 10.1373/clinchem.2005.056929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
654 Taniguchi H, Iwasaki Y, Fujiwara A, Sakaguchi K, Moriya A, Yu PC, Takaki A, Fujioka S, Shimomura H, Shiratori Y. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy. J Gastroenterol Hepatol 2006;21:281-7. [PMID: 16460487 DOI: 10.1111/j.1440-1746.2006.04201.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
655 Svirtlih N, Delic D, Simonovic-babic J, Maksic N, Gvozdenovic E, Dokic L, Boricic I, Pavic S, Draskovic D, Nesic Z. Predicting cirrhosis based on standard laboratory parameters in patients with chronic hepatitis C virus infection. Jugoslav Med Biohem 2006;25:255-261. [DOI: 10.2298/jmb0603255s] [Reference Citation Analysis]
656 Obrador BD, Prades MG, Gómez MV, Domingo JP, Cueto RB, Rué M, Real J, Guiteras PM. A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical, laboratory, and ultrasound findings. Eur J Gastroenterol Hepatol 2006;18:57-62. [PMID: 16357620 DOI: 10.1097/00042737-200601000-00010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
657 Huwart L, Peeters F, Sinkus R, Annet L, Salameh N, ter Beek LC, Horsmans Y, Van Beers BE. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006;19:173-9. [DOI: 10.1002/nbm.1030] [Cited by in Crossref: 326] [Cited by in F6Publishing: 334] [Article Influence: 19.2] [Reference Citation Analysis]
658 Blanc J, de Ledinghen V, Rosenbaum J. Fibrose hépatique. EMC - Hépatologie 2006;1:1-7. [DOI: 10.1016/s1155-1976(06)31588-4] [Reference Citation Analysis]
659 Martínez-Bauer E, Crespo J, Romero-Gómez M, Moreno-Otero R, Solá R, Tesei N, Pons F, Forns X, Sánchez-Tapias JM. Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C. Hepatology 2006;43:72-80. [PMID: 16374857 DOI: 10.1002/hep.21002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
660 Cadranel J, Castera L, Cales P. La ponction biopsie du foie dans le diagnostic et la prise en charge des maladies chroniques du foie. Gastroentérologie Clinique et Biologique 2006;30:121-3. [DOI: 10.1016/s0399-8320(06)73126-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
661 Calès P. Mesure de la fibrose hépatique. EMC - Hépatologie 2006;1:1-5. [DOI: 10.1016/s1155-1976(04)40074-6] [Reference Citation Analysis]
662 Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, Chen CW, Wang JY, Cai X, Gao CF, Zhou XQ. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005;42:1437-45. [PMID: 16317674 DOI: 10.1002/hep.20960] [Cited by in Crossref: 116] [Cited by in F6Publishing: 89] [Article Influence: 6.4] [Reference Citation Analysis]
663 Asselah T, Bièche I, Laurendeau I, Paradis V, Vidaud D, Degott C, Martinot M, Bedossa P, Valla D, Vidaud M, Marcellin P. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005;129:2064-75. [PMID: 16344072 DOI: 10.1053/j.gastro.2005.09.010] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 7.0] [Reference Citation Analysis]
664 Schneider AR, Teuber G, Kriener S, Caspary WF. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection. Liver Int 2005;25:1150-5. [PMID: 16343065 DOI: 10.1111/j.1478-3231.2005.01164.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
665 Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005;42:1373-81. [PMID: 16317693 DOI: 10.1002/hep.20935] [Cited by in Crossref: 388] [Cited by in F6Publishing: 329] [Article Influence: 21.6] [Reference Citation Analysis]
666 Sogni P, Salmon-céron D, Podevin P. Prise en charge des complications de la cirrhose chez les patients VIH co-infectés par une hépatite virale B ou C. La Presse Médicale 2005;34:1579-83. [DOI: 10.1016/s0755-4982(05)84228-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
667 Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36. [PMID: 16250051 DOI: 10.1002/hep.20933] [Cited by in Crossref: 4315] [Cited by in F6Publishing: 4057] [Article Influence: 239.7] [Reference Citation Analysis]
668 Ghany MG, Doo E. Assessment of liver fibrosis: palpate, poke or pulse? Hepatology 2005;42:759-61. [PMID: 16175617 DOI: 10.1002/hep.20913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
669 Herrine SK, Friedman LS. Divining the role of liver biopsy in hepatitis C. J Hepatol 2005;43:374-6. [PMID: 16046025 DOI: 10.1016/j.jhep.2005.06.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
670 Thuluvath PJ, Krok KL. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol 2005;100:1981-3. [PMID: 16128942 DOI: 10.1111/j.1572-0241.2005.00284.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
671 Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282-92. [PMID: 15986415 DOI: 10.1002/hep.20772] [Cited by in Crossref: 237] [Cited by in F6Publishing: 188] [Article Influence: 13.2] [Reference Citation Analysis]
672 Rosenthal-Allieri MA, Peritore ML, Tran A, Halfon P, Benzaken S, Bernard A. Analytical variability of the Fibrotest proteins. Clin Biochem. 2005;38:473-478. [PMID: 15820779 DOI: 10.1016/j.clinbiochem.2004.12.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
673 Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005;51:1867-1873. [PMID: 16055434 DOI: 10.1373/clinchem.2005.048389] [Cited by in Crossref: 387] [Cited by in F6Publishing: 412] [Article Influence: 21.5] [Reference Citation Analysis]
674 Halfon P, Bourlière M, Pénaranda G, Deydier R, Renou C, Botta-Fridlund D, Tran A, Portal I, Allemand I, Rosenthal-Allieri A. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005;4:6. [PMID: 16008833 DOI: 10.1186/1476-5926-4-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 5.3] [Reference Citation Analysis]
675 Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. J Hepatol 2005;43:78-84. [PMID: 15894397 DOI: 10.1016/j.jhep.2005.02.025] [Cited by in Crossref: 159] [Cited by in F6Publishing: 161] [Article Influence: 8.8] [Reference Citation Analysis]
676 Lee HS, Shun CT, Chiou LL, Chen CH, Huang GT, Sheu JC. Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J Gastroenterol Hepatol 2005;20:1109-14. [PMID: 15955222 DOI: 10.1111/j.1440-1746.2005.03901.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
677 Islam S, Antonsson L, Westin J, Lagging M. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol 2005;40:867-72. [PMID: 16109665 DOI: 10.1080/00365520510015674] [Cited by in Crossref: 105] [Cited by in F6Publishing: 90] [Article Influence: 5.8] [Reference Citation Analysis]
678 Zeremski M, Talal AH. Noninvasive markers of hepatic fibrosis: are they ready for prime time in the management of HIV/HCV co-infected patients? J Hepatol 2005;43:2-5. [PMID: 15922482 DOI: 10.1016/j.jhep.2005.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
679 Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376-82. [PMID: 15915455 DOI: 10.1002/hep.20717] [Cited by in Crossref: 238] [Cited by in F6Publishing: 188] [Article Influence: 13.2] [Reference Citation Analysis]
680 Gordon A, Bailey MJ, Gibson PR, Roberts SK. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C. J Gastroenterol Hepatol 2005;20:825-32. [PMID: 15946128 DOI: 10.1111/j.1440-1746.2005.03828.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
681 Vargas V. [Non-invasive methods for prediction of hepatic fibrosis in chronic hepatitis C]. Med Clin (Barc) 2005;124:775-7. [PMID: 15927104 DOI: 10.1157/13075850] [Reference Citation Analysis]
682 Romero Gómez M, Martín del Campo MR, Ángeles Otero M, Vallejo M, Corpas R, Castellano-megías VM. Estudio comparativo de dos modelos que utilizan parámetros bioquímicos en el diagnóstico no invasivo de la fibrosis hepática en pacientes con hepatitis C. Medicina Clínica 2005;124:761-4. [DOI: 10.1157/13075845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
683 Iacobellis A, Mangia A, Leandro G, Clemente R, Festa V, Attino V, Ricciardi R, Giacobbe A, Facciorusso D, Andriulli A. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis. Am J Gastroenterol 2005;100:868-73. [PMID: 15784034 DOI: 10.1111/j.1572-0241.2005.40881.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
684 Benlloch S, Berenguer M, Prieto M, Rayón JM, Aguilera V, Berenguer J. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index. Liver Transpl 2005;11:456-62. [PMID: 15776403 DOI: 10.1002/lt.20381] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
685 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/JCI200524282.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
686 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci24282] [Cited by in Crossref: 3381] [Cited by in F6Publishing: 3707] [Article Influence: 187.8] [Reference Citation Analysis]
687 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209-218. [PMID: 15690074 DOI: 10.1172/jci200524282] [Cited by in Crossref: 211] [Cited by in F6Publishing: 202] [Article Influence: 11.7] [Reference Citation Analysis]
688 Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, Sung JJ. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616-23. [PMID: 15743360 DOI: 10.1111/j.1572-0241.2005.41289.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 144] [Article Influence: 8.4] [Reference Citation Analysis]
689 Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18. [PMID: 15690074 DOI: 10.1172/JCI24282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
690 Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50. [PMID: 15685546 DOI: 10.1053/j.gastro.2004.11.018] [Cited by in Crossref: 1776] [Cited by in F6Publishing: 1894] [Article Influence: 98.7] [Reference Citation Analysis]
691 Sherman M. Screening for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19:101-18. [PMID: 15757807 DOI: 10.1016/j.bpg.2004.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
692 Imbert-Bismut F, Messous D, Thibault V, Myers RB, Piton A, Thabut D, Devers L, Hainque B, Mercadier A, Poynard T. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med. 2004;42:323-333. [PMID: 15080567 DOI: 10.1515/cclm.2004.058] [Cited by in Crossref: 62] [Cited by in F6Publishing: 80] [Article Influence: 3.4] [Reference Citation Analysis]
693 Saitou Y, Shiraki K, Yamanaka Y, Yamaguchi Y, Kawakita T, Yamamoto N, Sugimoto K, Murata K, Nakano T. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J Gastroenterol 2005; 11(4): 476-481 [PMID: 15641129 DOI: 10.3748/wjg.v11.i4.476] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 114] [Article Influence: 6.1] [Reference Citation Analysis]
694 Braden B, Faust D, Sarrazin U, Zeuzem S, Dietrich CF, Caspary WF, Sarrazin C. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2005;21:179-85. [PMID: 15679768 DOI: 10.1111/j.1365-2036.2005.02317.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
695 Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, Shiroma J, Toyama A, Nakayoshi T, Kinjo F, Saito A. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol 2005; 11(2): 255-259 [PMID: 15633226 DOI: 10.3748/wjg.v11.i2.255] [Cited by in CrossRef: 110] [Cited by in F6Publishing: 115] [Article Influence: 6.1] [Reference Citation Analysis]
696 Dioguardi N. 22 Reflections on the quantitative analysis of liver fibrosis in biopsy specimens. Multidisciplinary Approaches to Theory in Medicine 2005. [DOI: 10.1016/s1571-0831(06)80026-2] [Reference Citation Analysis]
697 Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54. [PMID: 15690481 DOI: 10.1002/hep.20506] [Cited by in Crossref: 1085] [Cited by in F6Publishing: 935] [Article Influence: 60.3] [Reference Citation Analysis]
698 Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005;42 Suppl:S22-36. [PMID: 15777570 DOI: 10.1016/j.jhep.2004.12.008] [Cited by in Crossref: 176] [Cited by in F6Publishing: 190] [Article Influence: 9.3] [Reference Citation Analysis]
699 Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem. 2005;51:328-335. [PMID: 15590748 DOI: 10.1373/clinchem.2004.041764] [Cited by in Crossref: 102] [Cited by in F6Publishing: 108] [Article Influence: 5.4] [Reference Citation Analysis]
700 Sebagh M, Samuel D. Place of the liver biopsy in liver transplantation. J Hepatol 2004;41:897-901. [PMID: 15582121 DOI: 10.1016/j.jhep.2004.10.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
701 Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-42. [PMID: 15582126 DOI: 10.1016/j.jhep.2004.08.008] [Cited by in Crossref: 243] [Cited by in F6Publishing: 241] [Article Influence: 12.8] [Reference Citation Analysis]
702 Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ; European Liver Fibrosis Group. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-13. [PMID: 15578508 DOI: 10.1053/j.gastro.2004.08.052] [Cited by in Crossref: 748] [Cited by in F6Publishing: 792] [Article Influence: 39.4] [Reference Citation Analysis]
703 Bissell DM. Assessing fibrosis without a liver biopsy: are we there yet? Gastroenterology 2004;127:1847-9. [PMID: 15578524 DOI: 10.1053/j.gastro.2004.10.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
704 Tanaka H, Tsukuma H, Yamano H, Oshima A, Shibata H. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer 2004;112:1075-80. [PMID: 15386355 DOI: 10.1002/ijc.20507] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
705 Teoh NC, Farrell GC. Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J. 2004;34:324-337. [PMID: 15228394 DOI: 10.1111/j.1445-5994.2004.00615.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
706 McCormick PA, Nolan N. Palpable epigastric liver as a physical sign of cirrhosis: a prospective study. Eur J Gastroenterol Hepatol 2004;16:1331-4. [PMID: 15618841 DOI: 10.1097/00042737-200412000-00016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
707 Acras RN, Pedroso ML, Caum LC, Pisani JC, Amarante HM, Carmes ER. [The sustained response rates for chronic hepatitis C patients undergoing therapy with the several interferons and ribavarins supplied by Brazilians Health Ministry is comparable to those reported in the literature]. Arq Gastroenterol 2004;41:3-9. [PMID: 15499417 DOI: 10.1590/s0004-28032004000100002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
708 Boyacioğlu S, Gür G, Yilmaz U, Korkmaz M, Demirhan B, Bilezikçi B, Ozdemir N. Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus. Transplant Proc 2004;36:50-2. [PMID: 15013298 DOI: 10.1016/j.transproceed.2003.11.066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
709 Tural C, Clotet B. La era del tratamiento antirretroviral de gran actividad… y de la coinfección por el virus de la hepatitis C. Medicina Clínica 2004;123:460-462. [DOI: 10.1016/s0025-7753(04)74555-8] [Reference Citation Analysis]
710 Quereda C, Moreno S, Moreno L, Moreno A, Garcı́a-sanmiguel L, Pérez-elı́as MJ, Navas E, Dronda F, Moreno A, Casado J, Antela A, López-san Román A. The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus. Human Pathology 2004;35:1083-7. [DOI: 10.1016/j.humpath.2004.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
711 Myara A, Guéchot J, Imbert-Bismut F, Lasnier E, Piton A, Voitot H, Férard G. Harmonization of liver enzyme results: calibration for aminotransferases and gamma glutamyltransferase. J Hepatol 2004;41:501-2. [PMID: 15336459 DOI: 10.1016/j.jhep.2004.04.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
712 Campisi G, Di Fede O, Craxı̀ A, Di Stefano R, Margiotta V. Oral lichen planus, hepatitis C virus, and HIV: No association in a cohort study from an area of high hepatitis C virus endemicity. Journal of the American Academy of Dermatology 2004;51:364-70. [DOI: 10.1016/j.jaad.2004.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
713 Calès P. Mesure de la fibrose hépatique. EMC - Hépatologie 2004;1:99-106. [DOI: 10.1016/j.emchep.2004.04.001] [Reference Citation Analysis]
714 Trinchet JC, Grando-Lemaire V. [Diagnosis of cirrhosis]. Gastroenterol Clin Biol 2004;28:D121-8. [PMID: 15213672 DOI: 10.1016/s0399-8320(04)94996-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]